ΚΩΔ. ΑΡ | ΚΩΔ. ΕΟΦ | ΟΝΟΜΑΣΙΑ | ΚΩΔ. Ε | ΠΕΡΙΓΡΑΦΗ ΕΤΑΙΡΕΙΑΣ | Ν.3816 | ΧΟΝΔΡΙΚΗ | ΝΟΣΟΚΟΜΕΙΑΚ | ΕΙΔΙΚΗ ΧΟΝΔΡΙΚΗ | ΛΙΑΝΙΚΗ | ||||
56133 | 267530101 | DUODOPA ENT. GEL (20+5)MG/ML BTx7 BAGSx100ML (BAG από PVC) | 505 | SOLVAY PHARM/CALS G | N | 774,74 | 674,02 | 687,50 | 849,34 | ||||
55942 | 272110103 | BRAMITOB INH.SOL.N (S.D) 300MG/4ML BTx56 (14 SACHETSx4AMPSx4 | 148 | CHIESI HELLAS AEBE | N | 1638,29 | 1425,31 | 1453,82 | 1796,05 | ||||
54203 | 248950101 | TOBI INH.SOL.N. BT 56AMPSx300MG/5ML | 321 | NOVARTIS HELLAS AEΒΕ | N | 2169,97 | 1887,87 | 1925,63 | 2378,92 | ||||
52944 | 225810101 | CAELYX CONCENTR.INF.INJ (IV) 1FLx10MLx2MG/ML | 476 | SP.EUROPE | N | 353,09 | 307,19 | 313,33 | 387,09 | ||||
55049 | 251340101 | MYOCET P.S.INJ.SOL.CON. 50MG 2 SET | 408 | WYETH EΛΛΑΣ ΑΕΒΕ | N | 1104,02 | 960,50 | 979,71 | 1210,33 | ||||
56293 | 264610102 | BUSILVEX C.S. SOL.INF 6MG/ML BT x 8VIALS x 10ML | 291 | PIERRE FABRE FARMAKA | N | 2484,79 | 2161,77 | 2205,01 | 2724,07 | ||||
54804 | 245110101 | GLIADEL IMPLANT BT 8x7,7MG | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 6792,02 | 5909,06 | 6027,24 | 7446,05 | ||||
50873 | 186110201 | SANDOGLOBULIN INJ LYOPH. FL 3GR+SOLV 100ML IV | 438 | CSL BEHRING Μ.ΕΠΕ | N | 112,72 | 98,07 | 100,03 | 123,58 | ||||
50874 | 186110301 | SANDOGLOBULIN INJ LYOPH FL 6GR+SOLV 200ML IV | 438 | CSL BEHRING Μ.ΕΠΕ | N | 224,63 | 195,43 | 199,34 | 246,26 | ||||
53030 | 220120301 | GAMMAGARD SD LY.PD.INJ 1BOTTLEx5G+1BOTTLEx96ML SOLV | 034 | BAXTER HELLAS ΕΠΕ | N | 220,21 | 191,58 | 195,41 | 241,41 | ||||
53861 | 223020101 | OCTAGAM SOL IV INF 5% FL 20ML | 256 | ΟΚΤΑΦΑΡΜΑ | N | 47,75 | 41,54 | 42,37 | 52,34 | ||||
53862 | 223020102 | OCTAGAM SOL IV INF 5% FL 50ML | 256 | ΟΚΤΑΦΑΡΜΑ | N | 89,25 | 77,65 | 79,20 | 97,84 | ||||
53859 | 223020103 | OCTAGAM SOL IV INF 5% FL 100ML | 256 | ΟΚΤΑΦΑΡΜΑ | N | 211,13 | 183,68 | 187,35 | 231,45 | ||||
53860 | 223020104 | OCTAGAM SOL IV INF 5% FL 200ML | 256 | ΟΚΤΑΦΑΡΜΑ | N | 338,39 | 294,40 | 300,29 | 370,98 | ||||
57132 | 292510102 | CAYSTON PS.SO.INHN 75 MG/VIAL 84 VIALS+88AMPS (PE) x 1ML SOLV | 068 | GILEAD | N | 3109,30 | 2705,09 | 2759,19 | 3408,70 | ||||
54057 | 193421201 | ROFERON-A INJ SOL 3MIU 1PF.SYR.x0,5ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 15,18 | 13,21 | 13,47 | 16,64 | ||||
54058 | 193421203 | ROFERON-A INJ SOL 3MIU 6PF.SYR.x0,5ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 91,11 | 79,27 | 80,86 | 99,89 | ||||
54059 | 193421301 | ROFERON-A INJ SOL 4.5MIU 1PF.SYR.x0,5ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 21,41 | 18,63 | 19,00 | 23,47 | ||||
54060 | 193421303 | ROFERON-A INJ SOL 4.5MIU 6PF.SYR.x0,5ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 128,46 | 111,76 | 114,00 | 140,84 | ||||
54061 | 193421401 | ROFERON-A INJ SOL 6MIU 1PF.SYR.x0,5ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 28,05 | 24,40 | 24,89 | 30,75 | ||||
54062 | 193421403 | ROFERON-A INJ SOL 6MIU 6PF.SYR.x0,5ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 187,57 | 163,19 | 166,45 | 205,63 | ||||
54063 | 193421501 | ROFERON-A INJ SOL 9MIU 1PF.SYR.x0,5ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 44,13 | 38,39 | 39,16 | 48,38 | ||||
54064 | 193421503 | ROFERON-A INJ SOL 9MIU 6PF.SYR.x0,5ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 192,48 | 167,46 | 170,81 | 211,02 | ||||
53979 | 245610101 | INTRONA PS INJ SOL 1MIU/VIAL + SOLV | 476 | SP.EUROPE | N | 4,53 | 3,94 | 4,02 | 4,97 | ||||
53974 | 245610501 | INTRONA INJ SOL 1VIAL x 3MIU/0,5ML | 476 | SP.EUROPE | N | 12,66 | 11,01 | 11,23 | 13,87 | ||||
53975 | 245610601 | INTRONA INJ SOL 1VIAL x 5MIU/0,5ML | 476 | SP.EUROPE | N | 20,00 | 17,40 | 17,75 | 21,93 | ||||
53972 | 245610701 | INTRONA INJ SOL 1VIAL x 10MIU/1ML | 476 | SP.EUROPE | N | 51,52 | 44,82 | 45,72 | 56,48 | ||||
54506 | 245610801 | INTRONA INJ SOL VIALx18MIU/3ML | 476 | SP.EUROPE | N | 90,23 | 78,50 | 80,07 | 98,92 | ||||
53973 | 245610901 | INTRONA INJ SOL 1VIAL x 25MIU/2,5ML MULTIDOSE | 476 | SP.EUROPE | N | 133,74 | 116,35 | 118,68 | 146,62 | ||||
53976 | 245611001 | INTRONA INJ SOL 18 MIU/1,2ML PEN MULTIDOSE | 476 | SP.EUROPE | N | 71,21 | 61,95 | 63,19 | 78,06 | ||||
53977 | 245611101 | INTRONA INJ SOL 30 MIU/1,2ML PEN MULTIDOSE | 476 | SP.EUROPE | N | 115,80 | 100,75 | 102,77 | 126,96 | ||||
53978 | 245611201 | INTRONA INJ SOL 60 MIU/1,2ML PEN MULTIDOSE | 476 | SP.EUROPE | N | 231,63 | 201,52 | 205,55 | 253,94 | ||||
53980 | 245611401 | INTRONA PS INJ SOL 30MIU/VIAL + SOLV | 476 | SP.EUROPE | N | 115,80 | 100,75 | 102,77 | 126,96 | ||||
41756 | 225670401 | SANDOSTATIN LAR PS.INJ.SUS 10MG/VIAL BTx1VIAL +1PF.SYRx2,5ML | 321 | NOVARTIS HELLAS AEΒΕ | N | 535,22 | 465,64 | 474,95 | 586,75 | ||||
41757 | 225670501 | SANDOSTATIN LAR PS.INJ.SUS 20MG/VIAL BTx1VIAL +1PF.SYRx2,5ML | 321 | NOVARTIS HELLAS AEΒΕ | N | 856,14 | 744,84 | 759,74 | 938,58 | ||||
41758 | 225670601 | SANDOSTATIN LAR PS.INJ.SUS 30MG/VIAL BTx1VIAL +1PF.SYRx2,5ML | 321 | NOVARTIS HELLAS AEΒΕ | N | 1110,83 | 966,42 | 985,75 | 1217,80 | ||||
52479 | 196470303 | EPREX ΙΝJ FL 6x10.000 IU/ML IV | 061 | JANSSEN-CILAG ΑΕΒΕ | N | 449,61 | 391,16 | 398,98 | 492,90 | ||||
52480 | 196470402 | EPREX INJ FL 6x1000IU/0.5ML IV | 061 | JANSSEN-CILAG ΑΕΒΕ | N | 44,90 | 39,06 | 39,84 | 49,22 | ||||
52481 | 196470601 | EPREX INJ FL 6x2000 IU/0,5 ML IV | 061 | JANSSEN-CILAG ΑΕΒΕ | N | 97,54 | 84,86 | 86,56 | 106,94 | ||||
52482 | 196470701 | EPREX INJ.SOL 3000IV/0,3ML BT 6PF .SYR X0,3ML | 061 | JANSSEN-CILAG ΑΕΒΕ | N | 139,36 | 121,24 | 123,66 | 152,77 | ||||
53660 | 196470801 | EPREX INJ SOL 6PF.SYRx4000IU/0.4ML | 061 | JANSSEN-CILAG ΑΕΒΕ | N | 185,79 | 161,64 | 164,87 | 203,68 | ||||
53938 | 196470901 | EPREX INJ SOL 1 VIALx40000 IU/ML | 061 | JANSSEN-CILAG ΑΕΒΕ | N | 293,93 | 255,72 | 260,83 | 322,23 | ||||
53939 | 196470902 | EPREX INJ SOL 4 VIALSx40000 IU/ML | 061 | JANSSEN-CILAG ΑΕΒΕ | N | 999,71 | 869,75 | 887,15 | 1095,99 | ||||
53940 | 196470903 | EPREX INJ SOL 6 VIALSx40000 IU/ML | 061 | JANSSEN-CILAG ΑΕΒΕ | N | 1517,01 | 1319,80 | 1346,20 | 1663,10 | ||||
54420 | 196471001 | EPREX INJ SOL 6PF SYRx5000IU/0,5ML | 061 | JANSSEN-CILAG ΑΕΒΕ | N | 236,17 | 205,47 | 209,58 | 258,92 | ||||
54421 | 196471101 | EPREX INJ SOL 6PF SYRx6000IU/0,6ML | 061 | JANSSEN-CILAG ΑΕΒΕ | N | 276,25 | 240,34 | 245,15 | 302,86 | ||||
54423 | 196471301 | EPREX INJ SOL 6PF SYRx8000IU/0,8ML | 061 | JANSSEN-CILAG ΑΕΒΕ | N | 372,33 | 323,93 | 330,41 | 408,19 | ||||
55699 | 196471501 | EPREX INJ.SOL 40000IU/1ML PF.SYR. BTx1PF.SYRx1ML | 061 | JANSSEN-CILAG ΑΕΒΕ | N | 291,52 | 253,62 | 258,69 | 319,59 | ||||
55700 | 196471502 | EPREX INJ.SOL 40000IU/1ML PF.SYR. BTx4PF.SYRx1ML | 061 | JANSSEN-CILAG ΑΕΒΕ | N | 1166,08 | 1014,49 | 1034,78 | 1278,37 | ||||
55701 | 196471503 | EPREX INJ.SOL 40000IU/1ML PF.SYR. BTx6PF.SYRx1ML | 061 | JANSSEN-CILAG ΑΕΒΕ | N | 1749,11 | 1521,73 | 1552,16 | 1917,54 | ||||
55696 | 196471601 | EPREX INJ.SOL 20000IU/0,5ML PF.SYR. BTx1PF.SYRx0,5ML | 061 | JANSSEN-CILAG ΑΕΒΕ | N | 161,90 | 140,85 | 143,67 | 177,49 | ||||
55697 | 196471602 | EPREX INJ.SOL 20000IU/0,5ML PF.SYR. BTx4PF.SYRx0,5ML | 061 | JANSSEN-CILAG ΑΕΒΕ | N | 503,97 | 438,45 | 447,22 | 552,50 | ||||
55698 | 196471603 | EPREX INJ.SOL 20000IU/0,5ML PF.SYR. BTx6PF.SYRx0,5ML | 061 | JANSSEN-CILAG ΑΕΒΕ | N | 971,38 | 845,10 | 862,00 | 1064,91 | ||||
56385 | 196471701 | EPREX INJ.SO.PFS 30.000IU/0,75ML PF.SYR BTx1PF.SYRx0,75ML | 061 | JANSSEN-CILAG ΑΕΒΕ | N | 258,80 | 225,16 | 229,66 | 283,72 | ||||
56386 | 196471702 | EPREX INJ.SO.PFS 30.000IU/0,75ML PF.SYR BTx4PF.SYRx0,75ML | 061 | JANSSEN-CILAG ΑΕΒΕ | N | 719,71 | 626,15 | 638,67 | 789,01 | ||||
56387 | 196471703 | EPREX INJ.SO.PFS 30.000IU/0,75ML PF.SYR BTx6PF.SYRx0,75ML | 061 | JANSSEN-CILAG ΑΕΒΕ | N | 1079,55 | 939,21 | 957,99 | 1183,50 | ||||
56225 | 284350102 | BINOCRIT INJ.SOL 1000IU/0,5ML PF.SYR. BTx6 | 339 | SANDOZ GMBH AUSTRIA | N | 32,33 | 28,13 | 28,69 | 35,44 | ||||
56226 | 284350202 | BINOCRIT INJ.SOL 2000IU/1ML PF.SYR. BTx6 | 339 | SANDOZ GMBH AUSTRIA | N | 65,39 | 56,89 | 58,03 | 71,69 | ||||
56227 | 284350302 | BINOCRIT INJ.SOL 3000IU/0,3ML PF.SYR. BTx6VIALx0,3ML | 339 | SANDOZ GMBH AUSTRIA | N | 98,09 | 85,34 | 87,05 | 107,54 | ||||
56228 | 284350402 | BINOCRIT INJ.SOL 4000IU/0,4ML PF.SYR. BTx6 | 339 | SANDOZ GMBH AUSTRIA | N | 130,79 | 113,79 | 116,07 | 143,39 | ||||
56229 | 284350502 | BINOCRIT INJ.SOL 5000IU/0,5ML PF.SYR. BTx6 | 339 | SANDOZ GMBH AUSTRIA | N | 163,49 | 142,24 | 145,08 | 179,23 | ||||
56230 | 284350602 | BINOCRIT INJ.SOL 6000IU/0,6ML PF.SYR. BTx6 | 339 | SANDOZ GMBH AUSTRIA | N | 196,18 | 170,68 | 174,09 | 215,07 | ||||
56231 | 284350702 | BINOCRIT INJ.SOL 8000IU/0,8ML PF.SYR. BTx6 | 339 | SANDOZ GMBH AUSTRIA | N | 261,57 | 227,57 | 232,12 | 286,76 | ||||
56224 | 284350802 | BINOCRIT INJ.SOL 10000IU/1,0ML PF.SYR. BTx6 | 339 | SANDOZ GMBH AUSTRIA | N | 326,97 | 284,46 | 290,15 | 358,45 | ||||
56763 | 284351102 | BINOCRIT 20000 IU/0.5l - Βt x 6 | 339 | SANDOZ GMBH AUSTRIA | N | 653,93 | 568,92 | 580,30 | 716,90 | ||||
56764 | 284351202 | BINOCRIT 30000 IU/0.5l - Bt x 6 | 339 | SANDOZ GMBH AUSTRIA | N | 980,89 | 853,37 | 870,44 | 1075,34 | ||||
56765 | 284351302 | BINOCRIT 40000 IU/0.5l - Bt x 6 | 339 | SANDOZ GMBH AUSTRIA | N | 1307,85 | 1137,83 | 1160,59 | 1433,79 | ||||
56350 | 285950101 | ABSEAMED INJ.SOL.PFS 1000IU/0,5ML BTx1PF.SYR | 662 | MEDICE ARZNEIMITTEL G | N | 6,29 | 5,47 | 5,58 | 6,89 | ||||
56351 | 285950102 | ABSEAMED INJ.SOL.PFS 1000IU/0,5ML BTx6PF.SYR | 662 | MEDICE ARZNEIMITTEL G | N | 34,92 | 30,38 | 30,99 | 38,29 | ||||
56352 | 285950201 | ABSEAMED INJ.SOL.PFS 2000IU/1,0ML BTx1PF.SYR | 662 | MEDICE ARZNEIMITTEL G | N | 11,65 | 10,14 | 10,34 | 12,77 | ||||
56353 | 285950202 | ABSEAMED INJ.SOL.PFS 2000IU/1,0ML BTx6PF.SYR | 662 | MEDICE ARZNEIMITTEL G | N | 70,62 | 61,44 | 62,67 | 77,42 | ||||
56354 | 285950301 | ABSEAMED INJ.SOL.PFS 3000IU/0,3ML BTx1PF.SYR | 662 | MEDICE ARZNEIMITTEL G | N | 17,50 | 15,22 | 15,52 | 19,17 | ||||
56355 | 285950302 | ABSEAMED INJ.SOL.PFS 3000IU/0,3ML BTx6PF.SYR | 662 | MEDICE ARZNEIMITTEL G | N | 105,94 | 92,17 | 94,01 | 116,14 | ||||
56356 | 285950401 | ABSEAMED INJ.SOL.PFS 4000IU/0,4ML BTx1PF.SYR | 662 | MEDICE ARZNEIMITTEL G | N | 23,17 | 20,15 | 20,55 | 25,39 | ||||
56357 | 285950402 | ABSEAMED INJ.SOL.PFS 4000IU/0,4ML BTx6PF.SYR | 662 | MEDICE ARZNEIMITTEL G | N | 141,25 | 122,89 | 125,35 | 154,86 | ||||
56358 | 285950501 | ABSEAMED INJ.SOL.PFS 5000IU/0,5ML BTx1PF.SYR | 662 | MEDICE ARZNEIMITTEL G | N | 29,17 | 25,38 | 25,89 | 31,98 | ||||
56359 | 285950502 | ABSEAMED INJ.SOL.PFS 5000IU/0,5ML BTx6PF.SYR | 662 | MEDICE ARZNEIMITTEL G | N | 176,57 | 153,62 | 156,69 | 193,57 | ||||
56360 | 285950601 | ABSEAMED INJ.SOL.PFS 6000IU/0,6ML BTx1PF.SYR | 662 | MEDICE ARZNEIMITTEL G | N | 34,99 | 30,44 | 31,05 | 38,36 | ||||
56361 | 285950602 | ABSEAMED INJ.SOL.PFS 6000IU/0,6ML BTx6PF.SYR | 662 | MEDICE ARZNEIMITTEL G | N | 211,87 | 184,33 | 188,02 | 232,28 | ||||
56362 | 285950701 | ABSEAMED INJ.SOL.PFS 8000IU/0,8ML BTx1PF.SYR | 662 | MEDICE ARZNEIMITTEL G | N | 46,68 | 40,61 | 41,42 | 51,17 | ||||
56363 | 285950702 | ABSEAMED INJ.SOL.PFS 8000IU/0,8ML BTx6PF.SYR | 662 | MEDICE ARZNEIMITTEL G | N | 282,50 | 245,77 | 250,69 | 309,70 | ||||
56348 | 285950801 | ABSEAMED INJ.SOL.PFS 10000IU/1,0ML BTx1PF.SYR | 662 | MEDICE ARZNEIMITTEL G | N | 56,26 | 48,94 | 49,92 | 61,67 | ||||
56349 | 285950802 | ABSEAMED INJ.SOL.PFS 10000IU/1,0ML BTx6PF.SYR | 662 | MEDICE ARZNEIMITTEL G | N | 353,13 | 307,22 | 313,36 | 387,12 | ||||
57119 | 285951101 | ABSEAMED INJ.SO.PFS 20.000 IU/0,5ML PF SYR BTx1PFS | 662 | MEDICE ARZNEIMITTEL G | N | 117,71 | 102,41 | 104,46 | 129,05 | ||||
57120 | 285951102 | ABSEAMED INJ.SO.PFS 20.000 IU/0,5ML PF SYR BTx6PFS | 662 | MEDICE ARZNEIMITTEL G | N | 706,24 | 614,43 | 626,72 | 774,25 | ||||
57121 | 285951201 | ABSEAMED INJ.SO.PFS 30.000 IU/0,5ML PF SYR BTx1PFS | 662 | MEDICE ARZNEIMITTEL G | N | 176,56 | 153,61 | 156,68 | 193,56 | ||||
57122 | 285951202 | ABSEAMED INJ.SO.PFS 30.000 IU/0,5ML PF SYR BTx6PFS | 662 | MEDICE ARZNEIMITTEL G | N | 1059,36 | 921,64 | 940,07 | 1161,36 | ||||
57123 | 285951301 | ABSEAMED INJ.SO.PFS 40.000 IU/1,0ML PF SYR BTx1PFS | 662 | MEDICE ARZNEIMITTEL G | N | 235,41 | 204,80 | 208,90 | 258,08 | ||||
57124 | 285951302 | ABSEAMED INJ.SO.PFS 40.000 IU/1,0ML PF SYR BTx6PFS | 662 | MEDICE ARZNEIMITTEL G | N | 1412,48 | 1228,86 | 1253,44 | 1548,50 | ||||
40892 | 197690101 | CYMEVENE INJ LYO. FL 12x500MG IV | 315 | ROCHE EΛΛAΣ ΑΕ | N | 170,53 | 148,36 | 151,33 | 186,95 | ||||
52557 | 197690102 | CYMEVENE LY.PD.INJ.IV FL 500 MG | 315 | ROCHE EΛΛAΣ ΑΕ | N | 20,56 | 17,89 | 18,25 | 22,55 | ||||
51899 | 201240101 | GRANULOKINE INJ.SOL. 30MU(300MCG)/1ML VIAL BTx5VIALSx1ML | 023 | AMGEN EUROPE B.V. | N | 312,83 | 272,16 | 277,60 | 342,95 | ||||
51900 | 201240201 | GRANULOKINE INJ.SOL.48MU(480MCG)/1,6ML VIAL BTx5VIALSx1,6ML | 023 | AMGEN EUROPE B.V. | N | 592,97 | 515,88 | 526,20 | 650,07 | ||||
55239 | 201240902 | GRANULOKINE INJ.SOL 5 PF SYRx30MU(300MCG)/0,5ML | 023 | AMGEN EUROPE B.V. | N | 307,82 | 267,80 | 273,16 | 337,46 | ||||
55240 | 201241002 | GRANULOKINE INJ.SOL 5 PF SYRx48MU(480MCG)/0,5ML | 023 | AMGEN EUROPE B.V. | N | 505,97 | 440,19 | 448,99 | 554,68 | ||||
56436 | 285240102 | TEVAGRASTIM INJ.SO.INF 30MIU (300MCG)/0,5ML BTx5PF.SYR | 663 | TEVA GMBH | N | 225,79 | 196,44 | 200,37 | 247,54 | ||||
56704 | 285240106 | TEVAGRASTIM INJ.SO INF 30MIU (300MCG)/0,5ML PF BTx5PF SYR με π | 663 | TEVA GMBH | N | 222,84 | 193,87 | 197,75 | 244,30 | ||||
56437 | 285240202 | TEVAGRASTIM INJ.SO.INF 48MIU (480MCG)/0,8ML BTx5PF.SYR | 663 | TEVA GMBH | N | 355,31 | 309,12 | 315,30 | 389,52 | ||||
56705 | 285240206 | TEVAGRASTIM INJ.SO INF 48MIU (480MCG)/0,8ML PF BTx5PF SYR με π | 663 | TEVA GMBH | N | 350,64 | 305,06 | 311,16 | 384,41 | ||||
57110 | 287970103 | ZARZIO SO.INJ.INF. 30MU(60MU/ML) 0,5 ML PF SYR BTx5PF. SYR | 339 | SANDOZ GMBH AUSTRIA | N | 224,85 | 195,62 | 199,53 | 246,50 | ||||
57111 | 287970203 | ZARZIO SO.INJ.INF. 48MU(96MU/ML) 0,5 ML PF SYR BTx5PF. SYR | 339 | SANDOZ GMBH AUSTRIA | N | 330,49 | 287,53 | 293,28 | 362,32 | ||||
57543 | 295050202 | NIVESTIM, INJ.SO.INF 30MU (300MCG/0,5ML), 5PF.SYR x 0,5ML | 654 | HOSPIRA UK LTD | N | 225,59 | 196,26 | 200,19 | 247,31 | ||||
57544 | 295050302 | NIVESTIM, INJ.SO.INF 48MU (480MCG/0,5ML), 5PF.SYR x 0,5ML | 654 | HOSPIRA UK LTD | N | 368,84 | 320,89 | 327,31 | 404,36 | ||||
55328 | 247280201 | NUTROPIN Aq INJ. SOL 10MG/2ML BT 1 CARTx2ML | 712 | IPSEN PHARMA FRANCE | N | 234,32 | 203,86 | 207,94 | 256,89 | ||||
55329 | 247280202 | NUTROPIN Aq INJ. SOL 10MG/2ML BT 3 CARTx2ML | 712 | IPSEN PHARMA FRANCE | N | 779,10 | 677,82 | 691,38 | 854,13 | ||||
55075 | 256250102 | VENTAVIS INH.SOL AMP 100x20MCG/2ML | 569 | BAYER SHERING PHARMA | N | 2300,22 | 2001,19 | 2041,21 | 2521,71 | ||||
56286 | 256250106 | VENTAVIS INH.SOL BTx90AMPSx2ML | 569 | BAYER SHERING PHARMA | N | 2094,22 | 1821,97 | 1858,41 | 2295,88 | ||||
52199 | 203940101 | IMUKIN INJ FL 0.1 MG/0.5ML SC | 214 | BOEHRINGER INGELHEIM | N | 82,40 | 71,69 | 73,12 | 90,33 | ||||
52263 | 209760101 | GRANOCYTE PS.INJ.SOL 33,6MIU(263mcg)BTxVIAL+1AMPx1ML SOLV | 518 | SANOFI-AVENTIS AEBE | N | 45,15 | 39,28 | 40,07 | 49,50 | ||||
52264 | 209760102 | GRANOCYTE PS.INJ.SOL 33,6MIU(263mcg)BTx5VIALS+5AMPSx1ML SOL | 518 | SANOFI-AVENTIS AEBE | N | 339,00 | 294,93 | 300,83 | 371,65 | ||||
56309 | 209760110 | GRANOCYTE PS.INJ.SOL.33,6MIU (263MCG)/VIAL BTx5VIALS+5PF.SYRx | 518 | SANOFI-AVENTIS AEBE | N | 339,00 | 294,93 | 300,83 | 371,65 | ||||
54038 | 228960601 | NEORECORMON PS INJ SOL 1VIALx50000IU+SOLV 10ML+SYSK+SYR | 315 | ROCHE EΛΛAΣ ΑΕ | N | 319,16 | 277,67 | 283,22 | 349,89 | ||||
54037 | 228960701 | NEORECORMON PS INJ SOL 1VIALx100000IU+SOLV 10ML+SYSK+SYR | 315 | ROCHE EΛΛAΣ ΑΕ | N | 638,32 | 555,34 | 566,45 | 699,79 | ||||
53851 | 228960801 | NEORECORMON PS.INJ.SOL 10000IU 1CARTR.X1ml | 315 | ROCHE EΛΛAΣ ΑΕ | N | 64,93 | 56,49 | 57,62 | 71,18 | ||||
53852 | 228960802 | NEORECORMON PS.INJ.SOL 10000IU 3CARTR.X1ml | 315 | ROCHE EΛΛAΣ ΑΕ | N | 189,59 | 164,94 | 168,24 | 207,84 | ||||
53853 | 228960901 | NEORECORMON PS.INJ.SOL 20000IU 1CARTR.X1ml | 315 | ROCHE EΛΛAΣ ΑΕ | N | 131,76 | 114,63 | 116,92 | 144,44 | ||||
53854 | 228960902 | NEORECORMON PS.INJ.SOL 20000IU 3CARTR.X1ml | 315 | ROCHE EΛΛAΣ ΑΕ | N | 395,29 | 343,90 | 350,78 | 433,35 | ||||
53496 | 228961001 | NEORECORMON SOL INJ 1PF.SYR. 500IUx0.3ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 3,40 | 2,96 | 3,02 | 3,73 | ||||
53503 | 228961002 | NEORECORMON SOL INJ 6PF.SYR. 500IUx0.3ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 20,33 | 17,69 | 18,04 | 22,29 | ||||
53491 | 228961101 | NEORECORMON SOL INJ 1PF.SYR. 1000IUx0.3ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 6,92 | 6,02 | 6,14 | 7,59 | ||||
53498 | 228961102 | NEORECORMON SOL INJ 6PF.SYR. 1000IUx0.3ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 41,48 | 36,09 | 36,81 | 45,48 | ||||
53493 | 228961201 | NEORECORMON SOL INJ 1PF.SYR. 2000IUx0.3ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 14,07 | 12,24 | 12,48 | 15,42 | ||||
53500 | 228961202 | NEORECORMON SOL INJ 6PF.SYR. 2000IUx0.3ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 98,46 | 85,66 | 87,37 | 107,94 | ||||
53494 | 228961301 | NEORECORMON SOL INJ 1PF.SYR. 3000IUx0.3ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 20,32 | 17,68 | 18,03 | 22,27 | ||||
53501 | 228961302 | NEORECORMON SOL INJ 6PF.SYR. 3000IUx0.3ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 147,76 | 128,55 | 131,12 | 161,99 | ||||
53495 | 228961401 | NEORECORMON SOL INJ 1PF.SYR. 5000IUx0.3ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 33,67 | 29,29 | 29,88 | 36,91 | ||||
53502 | 228961402 | NEORECORMON SOL INJ 6PF.SYR. 5000IUx0.3ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 246,45 | 214,41 | 218,70 | 270,18 | ||||
53490 | 228961501 | NEORECORMON SOL INJ 1PF.SYR. 10000IUx0.6ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 65,57 | 57,05 | 58,19 | 71,89 | ||||
53497 | 228961502 | NEORECORMON SOL INJ 6PF.SYR. 10000IUx0.6ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 498,37 | 433,58 | 442,25 | 546,36 | ||||
53492 | 228961601 | NEORECORMON SOL INJ 1PF.SYR. 20000IUx0.6ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 127,67 | 111,07 | 113,29 | 139,96 | ||||
53499 | 228961602 | NEORECORMON SOL INJ 6PF.SYR. 20000IUx0.6ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 765,98 | 666,40 | 679,73 | 839,74 | ||||
54168 | 228961701 | NEORECORMON PS.INJ SOL 60000IU 1 CARTRx1ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 395,29 | 343,90 | 350,78 | 433,35 | ||||
54169 | 228961702 | NEORECORMON PS.INJ SOL 60000IU 3 CARTRx1ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 1185,86 | 1031,70 | 1052,33 | 1300,05 | ||||
54035 | 228961802 | NEORECORMON INJ SOL 6PF SYR 4000 IU x 0,3ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 197,10 | 171,48 | 174,91 | 216,08 | ||||
54036 | 228961902 | NEORECORMON INJ SOL 6PF SYR 6000 IU x 0,3ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 295,84 | 257,38 | 262,53 | 324,33 | ||||
55050 | 228962001 | NEORECORMON SOL.INJ. 1PF.SYR 30000IUx0,6ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 190,18 | 165,46 | 168,77 | 208,50 | ||||
55051 | 228962002 | NEORECORMON SOL.INJ. 4PF.SYR 30000IUx0,6ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 967,15 | 841,42 | 858,25 | 1060,28 | ||||
52630 | 209850101 | NAVELBINE INJ.SOL.BT 1 VIAL X10MG/ML | 291 | PIERRE FABRE FARMAKA | N | 17,57 | 15,29 | 15,60 | 19,27 | ||||
52631 | 209850401 | NAVELBINE INJ.SOL.BT 1 VIAL X50MG/ML | 291 | PIERRE FABRE FARMAKA | N | 61,62 | 53,61 | 54,68 | 67,55 | ||||
54918 | 209850501 | NAVELBINE SOFT. CAPS BT 1x20MG | 291 | PIERRE FABRE FARMAKA | N | 35,16 | 30,59 | 31,20 | 38,54 | ||||
54919 | 209850601 | NAVELBINE SOFT. CAPS BT 1x30MG | 291 | PIERRE FABRE FARMAKA | N | 52,73 | 45,88 | 46,80 | 57,82 | ||||
55842 | 272160101 | VINORELBIN/EBEWE C/S SOL IN 10MG/ML BTx1VIALx1ML | 564 | EBEWE PHARMA GMBH | N | 14,93 | 12,99 | 13,25 | 16,37 | ||||
55843 | 272160102 | VINORELBIN/EBEWE C/S SOL IN 10MG/ML BTx1VIALx5ML | 564 | EBEWE PHARMA GMBH | N | 52,38 | 45,57 | 46,48 | 57,42 | ||||
52390 | 221320101 | PULMOZYME SOL INH FL 6x2500U/2,5ML (1 DOSE AMP) | 315 | ROCHE EΛΛAΣ ΑΕ | N | 115,78 | 100,73 | 102,74 | 126,92 | ||||
52469 | 210970401 | TAXOL CS.SOL.INF (CONCENTRATE) 6MG/ML BTx1VIAL 30MG/5ML | 460 | BRISTOL-MYERS SQUIBB | N | 70,81 | 61,60 | 62,83 | 77,62 | ||||
53232 | 210970403 | TAXOL CS.SOL.INF (CONCENTRATE) 6MG/ML BTx1VIAL MULTIDOSE 10 | 460 | BRISTOL-MYERS SQUIBB | N | 235,45 | 204,84 | 208,94 | 258,12 | ||||
56027 | 210970405 | TAXOL CS. SOL. INF.(Concentrate) 6MG/ML BTx1 VIAL MULTIDOSE (30 | 460 | BRISTOL-MYERS SQUIBB | N | 673,62 | 586,05 | 597,77 | 738,49 | ||||
55407 | 210970406 | TAXOL CS. SOL. INF.(Concentrate) 6MG/ML BTx1(VIALx25MLx150MG) | 460 | BRISTOL-MYERS SQUIBB | N | 272,35 | 236,94 | 241,68 | 298,57 | ||||
55052 | 248360301 | PAXENE CS.SOL.NF 1VIAL 17MLx6MG/ML | 060 | ΓEPOΛYMATOΣ Π.N ΑΕΒΕ | N | 200,13 | 174,11 | 177,59 | 219,39 | ||||
55053 | 248360401 | PAXENE CS.SOL.NF 1VIAL 50MLx6MG/ML | 060 | ΓEPOΛYMATOΣ Π.N ΑΕΒΕ | N | 572,58 | 498,14 | 508,10 | 627,71 | ||||
41488 | 253950101 | BIOTAXEL SOLUTION FOR INJ. BTx1VIAL (30MG)x5ML (MONODOSE) | 223 | MEDICUS ΑΕ | N | 60,19 | 52,37 | 53,42 | 66,00 | ||||
41487 | 253950102 | BIOTAXEL SOLUTION FOR INJ BTx1VIAL (100MG)x16,7ML (MULTIDOSE) | 223 | MEDICUS ΑΕ | N | 200,13 | 174,11 | 177,59 | 219,39 | ||||
41932 | 253950103 | BIOTAXEL CS.SOL.INF 6MG/1ML BTx1 VIAL (150MG) x 25ML (MULTIDO | 223 | MEDICUS ΑΕ | N | 265,18 | 230,71 | 235,32 | 290,71 | ||||
41933 | 253950104 | BIOTAXEL CS.SOL.INF 6MG/1ML BTx1 VIAL (300MG) x 50ML (MULTIDO | 223 | MEDICUS ΑΕ | N | 572,58 | 498,14 | 508,10 | 627,71 | ||||
55346 | 263360401 | PACLITOL CS.SOL.INF. BTx1VIAL 30MG/5ML (MONODOSE) | 388 | ΦΑΡΜΑΝΕΛ ΦΑΡΜ/ΚΗ Α | N | 60,19 | 52,37 | 53,42 | 66,00 | ||||
55344 | 263360402 | PACLITOL CS.SOL.INF. BTx1VIAL 100MG/16,7ML (MULTIDOSE) | 388 | ΦΑΡΜΑΝΕΛ ΦΑΡΜ/ΚΗ Α | N | 200,13 | 174,11 | 177,59 | 219,39 | ||||
55345 | 263360403 | PACLITOL CS.SOL.INF. BTx1VIAL 300MG/50ML (MULTIDOSE) | 388 | ΦΑΡΜΑΝΕΛ ΦΑΡΜ/ΚΗ Α | N | 572,58 | 498,14 | 508,10 | 627,71 | ||||
41643 | 263680301 | TAXOPROL CS.SOL.INF. BTx1VIAL(30MG)X5ML (MONODOSE) | 700 | NOVENDIA PHARMACEU | N | 60,19 | 52,37 | 53,42 | 66,00 | ||||
41642 | 263680302 | TAXOPROL CS.SOL.INF. BTx1VIAL(100MG)X16,7ML (MULTIDOSE) | 700 | NOVENDIA PHARMACEU | N | 200,13 | 174,11 | 177,59 | 219,39 | ||||
42404 | 263680303 | TAXOPROL CS.SOL. INF 6MG/ML BTx1VIAL(300MG)X50ml(MULTIDOSE) | 700 | NOVENDIA PHARMACEU | N | 518,35 | 450,96 | 459,98 | 568,26 | ||||
41588 | 263810301 | PACLIXEL CS.SOL.INF 6MG/ML BTx1 VIAL (30MG)X5ML | 446 | NOVAGEN PHARMACEUT | N | 60,19 | 52,37 | 53,42 | 66,00 | ||||
41587 | 263810302 | PACLIXEL CS.SOL.INF 6MG/ML BTx1 VIAL (100MG)X16,7ML | 446 | NOVAGEN PHARMACEUT | N | 200,13 | 174,11 | 177,59 | 219,39 | ||||
12192 | 263870101 | PATAXEL BTx1VIAL (30MG) x 5ML (MONODOSE) | 040 | BIANEΞ AE | N | 60,19 | 52,37 | 53,42 | 66,00 | ||||
12190 | 263870102 | PATAXEL BTx1VIAL (100MG) x 16,7ML (MULTIDOSE) | 040 | BIANEΞ AE | N | 200,13 | 174,11 | 177,59 | 219,39 | ||||
12191 | 263870103 | PATAXEL BTx1VIAL (300MG) x 50ML (MULTIDOSE) | 040 | BIANEΞ AE | N | 572,58 | 498,14 | 508,10 | 627,71 | ||||
55340 | 266380101 | PACLITAXEL/HOSPIRA CS.SOL.INF. BTx1VIALx5MLx6MG/ML | 654 | HOSPIRA UK LTD | N | 60,19 | 52,37 | 53,42 | 66,00 | ||||
55337 | 266380102 | PACLITAXEL/HOSPIRA CS.SOL.INF. BTx1VIALx16,7MLx6MG/ML | 654 | HOSPIRA UK LTD | N | 200,13 | 174,11 | 177,59 | 219,39 | ||||
55338 | 266380103 | PACLITAXEL/HOSPIRA CS.SOL.INF. BTx1VIALx25MLx6MG/ML | 654 | HOSPIRA UK LTD | N | 231,50 | 201,41 | 205,44 | 253,80 | ||||
55339 | 266380104 | PACLITAXEL/HOSPIRA CS.SOL.INF. BTx1VIALx50MLx6MG/ML | 654 | HOSPIRA UK LTD | N | 572,58 | 498,14 | 508,10 | 627,71 | ||||
55564 | 267290101 | OVAPAC CS.SOL.INF 6MG/ML BTx1 VIAL (30MG/5ML) | 639 | ΦΑΡΜΑΤΕΝ ΕΛΛΑΣ ΑΕΒΕ | N | 60,19 | 52,37 | 53,42 | 66,00 | ||||
55563 | 267290102 | OVAPAC CS.SOL.INF 6MG/ML BTx1 VIAL (100MG/16,7ML) | 639 | ΦΑΡΜΑΤΕΝ ΕΛΛΑΣ ΑΕΒΕ | N | 200,13 | 174,11 | 177,59 | 219,39 | ||||
55565 | 267290103 | OVAPAC CS.SOL.INF 6MG/ML BTx10 VIAL (30MG/5ML) | 639 | ΦΑΡΜΑΤΕΝ ΕΛΛΑΣ ΑΕΒΕ | N | 601,89 | 523,64 | 534,11 | 659,84 | ||||
41956 | 272000101 | ONCOTAXEN CS.SOL.INF 6MG/ML BTx1 (VIALx100MG) x17ML | 327 | SAMBROOK | N | 200,13 | 174,11 | 177,59 | 219,39 | ||||
41957 | 272000102 | ONCOTAXEN CS.SOL.INF 6MG/ML BTx1 (VIALx300MG) x50ML | 327 | SAMBROOK | N | 572,58 | 498,14 | 508,10 | 627,71 | ||||
55902 | 275010101 | PACLITAXEL/GENERICS CS.SOL.INF. 6MG/ML BTx 1VIALx5ML (30MG/5 | 351 | GENERICS PHAR.HELLAS Ε | N | 60,19 | 52,37 | 53,42 | 66,00 | ||||
55901 | 275010102 | PACLITAXEL/GENERICS CS.SOL.INF. 6MG/ML BTx 1VIALx16,7ML (100M | 351 | GENERICS PHAR.HELLAS Ε | N | 200,13 | 174,11 | 177,59 | 219,39 | ||||
55343 | 277400101 | PAXENE PACLITAXEL CS.SOL.INF. 6MG/ML BTx1VIALx5ML | 608 | PHARMACHEMIE B.V. HO | N | 60,19 | 52,37 | 53,42 | 66,00 | ||||
55341 | 277400102 | PAXENE PACLITAXEL CS.SOL.INF. 6MG/ML BTx1VIALx16,7ML | 608 | PHARMACHEMIE B.V. HO | N | 200,13 | 174,11 | 177,59 | 219,39 | ||||
55342 | 277400103 | PAXENE PACLITAXEL CS.SOL.INF. 6MG/ML BTx1VIALx50ML | 608 | PHARMACHEMIE B.V. HO | N | 572,58 | 498,14 | 508,10 | 627,71 | ||||
56011 | 277400104 | PAXENE PACLITAXEL CS.SOL.INF 6MG/ML BTx1VIALx25ML | 608 | PHARMACHEMIE B.V. HO | N | 231,50 | 201,41 | 205,44 | 253,80 | ||||
12270 | 277490101 | PAXITAL CS.SOL.INF. 6MG/ML BTx1VIAL(30MG)x5ML (MONODOSE) | 590 | MEDICAMERC AE | N | 60,19 | 52,37 | 53,42 | 66,00 | ||||
12269 | 277490102 | PAXITAL CS.SOL.INF. 6MG/ML BTx1VIAL(100MG)x16,7ML (MULTIDOSE) | 590 | MEDICAMERC AE | N | 200,13 | 174,11 | 177,59 | 219,39 | ||||
14032 | 277490103 | PAXITAL CS.SOL.INF 6MG/ML BTx1VIAL (150MG) x25ML (MULTIDOSE) | 590 | MEDICAMERC AE | N | 231,50 | 201,41 | 205,44 | 253,80 | ||||
14033 | 277490104 | PAXITAL CS.SOL.INF 6MG/ML BTx1VIAL (300MG) x50ML (MULTIDOSE) | 590 | MEDICAMERC AE | N | 572,58 | 498,14 | 508,10 | 627,71 | ||||
57264 | 281730101 | PACLITAXEL KABI C/S.SOL.IN 6MG/ML BTx1VIALx5ML | 393 | FRESENIUS KABI HELLAS | N | 55,78 | 48,53 | 49,50 | 61,15 | ||||
57263 | 281730102 | PACLITAXEL KABI C/S.SOL.IN 6MG/ML BTx1VIALx16,7ML | 393 | FRESENIUS KABI HELLAS | N | 179,27 | 155,96 | 159,08 | 196,53 | ||||
57268 | 281730103 | PACLITAXEL KABI C/S.SOL.IN 6MG/ML C/S.SOL.IN 6MG/ML BTx1VIALx | 393 | FRESENIUS KABI HELLAS | N | 518,35 | 450,96 | 459,98 | 568,26 | ||||
57267 | 281730104 | PACLITAXEL KABI C/S.SOL.IN 6MG/ML BTx5VIALSx5ML | 393 | FRESENIUS KABI HELLAS | N | 278,93 | 242,67 | 247,52 | 305,79 | ||||
57265 | 281730105 | PACLITAXEL KABI C/S.SOL.IN 6MG/ML BTx5VIALSx16,7ML | 393 | FRESENIUS KABI HELLAS | N | 896,39 | 779,86 | 795,46 | 982,71 | ||||
57266 | 281730106 | PACLITAXEL KABI C/S.SOL.IN 6MG/ML BTx5VIALSX50ML | 393 | FRESENIUS KABI HELLAS | N | 2591,79 | 2254,86 | 2299,96 | 2841,37 | ||||
56522 | 287850101 | XENIUS CS.SOL.INF 6MG/1ML BTx1VIALx5ML | 686 | MAK A.Σ.Φ.Ε. ΕΙΣΑΓ.& Ε | N | 60,19 | 52,37 | 53,42 | 66,00 | ||||
56521 | 287850102 | XENIUS CS.SOL.INF 6MG/1ML BTx1VIALx25ML | 686 | MAK A.Σ.Φ.Ε. ΕΙΣΑΓ.& Ε | N | 231,50 | 201,41 | 205,44 | 253,80 | ||||
56590 | 287850103 | XENIUS CS.SOL.INF 6MG/1ML BTx1VIALx17ML | 686 | MAK A.Σ.Φ.Ε. ΕΙΣΑΓ.& Ε | N | 200,13 | 174,11 | 177,59 | 219,39 | ||||
56591 | 287850104 | XENIUS CS.SOL.INF 6MG/1ML BTx1VIALx50ML | 686 | MAK A.Σ.Φ.Ε. ΕΙΣΑΓ.& Ε | N | 572,58 | 498,14 | 508,10 | 627,71 | ||||
57135 | 293170101 | CEDOL C/S SOL. IN 6MG/ML BOX x 1VIAL x 30MG | 064 | GAP AE | N | 67,11 | 58,39 | 59,56 | 73,58 | ||||
57138 | 293170102 | CEDOL C/S SOL. IN 6MG/ML BTx 10 BOXES x 1VIAL x 30MG | 064 | GAP AE | N | 623,68 | 542,60 | 553,45 | 683,73 | ||||
57134 | 293170103 | CEDOL C/S SOL. IN 6MG/ML BOX x 1VIAL x 300MG | 064 | GAP AE | N | 623,68 | 542,60 | 553,45 | 683,73 | ||||
57136 | 293170104 | CEDOL C/S SOL. IN 6MG/ML BTx 10 BOXES x 1VIAL x 100MG | 064 | GAP AE | N | 1898,16 | 1651,40 | 1684,43 | 2080,94 | ||||
57133 | 293170105 | CEDOL C/S SOL. IN 6MG/ML BOX x 1VIAL x 100MG | 064 | GAP AE | N | 215,70 | 187,66 | 191,41 | 236,47 | ||||
57137 | 293170106 | CEDOL C/S SOL. IN 6MG/ML BTx 10 BOXES x 1VIAL x 300MG | 064 | GAP AE | N | 5488,38 | 4774,89 | 4870,39 | 6016,88 | ||||
52679 | 220060101 | ETHYOL PD.SOL.INF 500MG/VIAL BTx3 VIALx500MG | 636 | PINNACLE BIOLOGICALS | N | 676,32 | 588,40 | 600,17 | 741,45 | ||||
52704 | 221540101 | FLUDARA LY.PD.INJ.BT5VIALSX50MG | 465 | GENZYME BV, NEDERLAN | N | 1352,15 | 1176,37 | 1199,90 | 1482,36 | ||||
54605 | 221540201 | FLUDARA F.C.TABL BT 15x10MG | 465 | GENZYME BV, NEDERLAN | N | 128,26 | 111,59 | 113,82 | 140,61 | ||||
54606 | 221540202 | FLUDARA F.C.TABL BT 20x10MG | 465 | GENZYME BV, NEDERLAN | N | 223,39 | 194,35 | 198,24 | 244,91 | ||||
56478 | 275480101 | FLUDARABIN/EBEWE INJ.SOL/CS.SOL.INF 25MG/ML BTx1VIALx2ML | 564 | EBEWE PHARMA GMBH | N | 82,54 | 71,81 | 73,25 | 90,49 | ||||
56479 | 275480102 | FLUDARABIN/EBEWE INJ.SOL/CS.SOL.INF 25MG/ML BTx5VIALSx2ML | 564 | EBEWE PHARMA GMBH | N | 396,30 | 344,78 | 351,68 | 434,47 | ||||
56477 | 275480103 | FLUDARABIN/EBEWE INJ.SOL/CS.SOL.INF 25MG/ML BTx10VIALSx2ML | 564 | EBEWE PHARMA GMBH | N | 638,84 | 555,79 | 566,91 | 700,36 | ||||
52758 | 222130101 | LEUSTATIN INJ SO INF 10MG/10ML BT 7VIALS X 10ML | 061 | JANSSEN-CILAG ΑΕΒΕ | N | 792,60 | 689,56 | 703,35 | 868,92 | ||||
56313 | 258020101 | LITAK INJ.SOL 2MG/ML BTx1 VIALx5ML | 640 | LIPOMED GMBH | N | 1600,00 | 1392,00 | 1419,84 | 1754,07 | ||||
56314 | 258020102 | LITAK INJ.SOL 2MG/ML BTx5 VIALx5ML | 640 | LIPOMED GMBH | N | 1526,80 | 1328,32 | 1354,89 | 1673,83 | ||||
52820 | 223850103 | BETAFERON LY PD INJ 0,3 MG/VIAL BT 15 VIALS +15 PF.SYRX 2 ML SOLV | 569 | BAYER SHERING PHARMA | N | 682,20 | 593,51 | 605,38 | 747,89 | ||||
56464 | 223850108 | BETAFERON PS.INJ.SOL 0,25MG/ML 12BTx1VIALx1PF.SYRx1,2ML SOLV | 569 | BAYER SHERING PHARMA | N | 517,33 | 450,08 | 459,08 | 567,15 | ||||
52938 | 227250102 | AVONEX PS.INJ.SOL 4VIALx30MCG/3ML+4PF.SYR | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 593,54 | 516,38 | 526,71 | 650,70 | ||||
54905 | 227250201 | AVONEX INJ.SOL 4 PF SYRx30MCG/0,5ML | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 750,69 | 653,10 | 666,16 | 822,97 | ||||
53541 | 233240601 | REBIF-22MCG(6MIU) INJ SOL 1PF.SYRx0.5ML | 326 | SERONO HELLAS ΑΕ | N | 50,53 | 43,96 | 44,84 | 55,40 | ||||
53542 | 233240602 | REBIF-22MCG(6MIU) INJ SOL 3PF.SYRx0.5ML | 326 | SERONO HELLAS ΑΕ | N | 192,63 | 167,59 | 170,94 | 211,18 | ||||
53540 | 233240603 | REBIF-22MCG(6MIU) INJ SOL 12PF.SYRx0.5ML | 326 | SERONO HELLAS ΑΕ | N | 770,79 | 670,59 | 684,00 | 845,01 | ||||
54186 | 233240801 | REBIF-44 MCG(12 MIU) INJ SOL 1 PF SYRx1ML | 326 | SERONO HELLAS ΑΕ | N | 68,32 | 59,44 | 60,63 | 74,90 | ||||
54188 | 233240802 | REBIF-44 MCG(12 MIU) INJ SOL 3 PF SYRx1ML | 326 | SERONO HELLAS ΑΕ | N | 221,13 | 192,38 | 196,23 | 242,42 | ||||
54187 | 233240803 | REBIF-44 MCG(12 MIU) INJ SOL 12 PF SYRx1ML | 326 | SERONO HELLAS ΑΕ | N | 884,33 | 769,37 | 784,76 | 969,49 | ||||
56607 | 233241001 | REBIF INJ.SOL 66MCG (22MCG/0,5ML)/1,5ML BTx4 CARTRIDGES | 483 | SERONO (EUROPE) LTD U | N | 804,52 | 699,93 | 713,93 | 881,99 | ||||
56606 | 233241101 | REBIF INJ.SOL 132MCG (44MCG/0,5ML)/1,5ML BTx4 CARTRIDGES | 483 | SERONO (EUROPE) LTD U | N | 929,06 | 808,28 | 824,45 | 1018,53 | ||||
55767 | 223850105 | BETAFERON PS.INJ.SOL BTx(15BTx1VIAL+1PF.SYRx1,2ML SOLV+1προσ | 569 | BAYER SHERING PHARMA | N | 740,78 | 644,48 | 657,37 | 812,11 | ||||
56391 | 284330102 | EXTAVIA PS.INJ.SOL 250MCG/ML BTx15VIALS+15PF.SYRSx1,2ML SOLV | 517 | NOVARTIS EUROPHARM | N | 762,08 | 663,01 | 676,27 | 835,46 | ||||
56390 | 284330103 | EXTAVIA PS.INJ.SOL 250MCG/ML 3x15VIALS+3x15PF.SYRSx1,2ML SOLV | 517 | NOVARTIS EUROPHARM | N | 1843,29 | 1603,66 | 1635,73 | 2020,78 | ||||
52596 | 224860101 | TAXOTERE INJ CO INF 1VIALx20MG/0,5ML | 316 | AVENTIS PHARMA ΑΒΕE | N | 101,06 | 87,92 | 89,68 | 110,79 | ||||
52597 | 224860201 | TAXOTERE 80MG/2,0ML/1VIAL | 316 | AVENTIS PHARMA ΑΒΕE | N | 395,25 | 343,87 | 350,75 | 433,32 | ||||
57380 | 278810101 | DOCETAXEL/HOSPIRA, C/S.SOL.IN, 10MG/ML, BT x 1VIALX2ML (20MG | 654 | HOSPIRA UK LTD | N | 117,04 | 101,82 | 103,86 | 128,31 | ||||
57379 | 278810102 | DOCETAXEL/HOSPIRA, C/S.SOL.IN 10MG/ML, BT x 1VIALX8ML (80MG/ | 654 | HOSPIRA UK LTD | N | 454,57 | 395,48 | 403,39 | 498,35 | ||||
57378 | 278810103 | DOCETAXEL/HOSPIRA, C/S.SOL.IN 10MG/ML, BT x 1VIALX16ML (160M | 654 | HOSPIRA UK LTD | N | 849,93 | 739,44 | 754,23 | 931,78 | ||||
57707 | 224860301 | TAXOTERE CS SOL INF 20MG/1ML BTx1VIALx1ML | 316 | AVENTIS PHARMA S.A. | N | 130,05 | 113,14 | 115,40 | 142,57 | ||||
57708 | 224860401 | TAXOTERE CS SOL INF 80MG/4ML BTx1VIALx4ML | 316 | AVENTIS PHARMA S.A. | N | 505,08 | 439,42 | 448,21 | 553,72 | ||||
57709 | 224860501 | TAXOTERE, CS.SOL.INF. 160MG/8ML, BT X 1 VIAL | 316 | AVENTIS PHARMA | N | 944,35 | 821,58 | 838,01 | 1035,28 | ||||
56840 | 293810101 | DOCETAXEL TEVA C.SO.S.INF 20 MG/0,72 ML VIAL (1 VIAL x 0,72 ML + 1 | 644 | TEVA PHARMA B.V. | N | 85,90 | 74,73 | 76,22 | 94,16 | ||||
56841 | 293810201 | DOCETAXEL TEVA C.SO.S.INF 80 MG/2,88 ML VIAL (1 VIAL x 2,88 ML + 1 | 644 | TEVA PHARMA B.V. | N | 335,96 | 292,29 | 298,14 | 368,32 | ||||
52555 | 225540101 | CELLCEPT CAPS BT 100X250 MG | 315 | ROCHE EΛΛAΣ ΑΕ | N | 73,11 | 63,61 | 64,88 | 80,15 | ||||
52961 | 225540201 | CELLCEPT TABL 50x500MG | 315 | ROCHE EΛΛAΣ ΑΕ | N | 73,11 | 63,61 | 64,88 | 80,15 | ||||
53926 | 225540301 | CELLCEPT PD.OR.SOL 1G/5ML FL.110G | 315 | ROCHE EΛΛAΣ ΑΕ | N | 122,13 | 106,25 | 108,38 | 133,89 | ||||
53686 | 225540401 | CELLCEPT CS.SOL.INF. 4VIALx500MG/20ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 35,79 | 31,14 | 31,76 | 39,24 | ||||
56324 | 283640101 | MYFENAX CAPS 250MG/CAP BTx100 σε BLISTERS (PVC/PVDC/ALU) | 644 | TEVA PHARMA B.V. | N | 62,14 | 54,06 | 55,14 | 68,12 | ||||
57535 | 283640102 | MYFENAX, CAPS 250MG/CAP, BTX300 BLISTER (PVC/PVDC/ALU) | 644 | TEVA PHARMA BV | N | 182,50 | 158,78 | 161,96 | 200,09 | ||||
56325 | 283640201 | MYFENAX F.C. TAB 500MG/TAB BTx50 σε BLISTERS (PVC/PVDC/ALU) | 644 | TEVA PHARMA B.V. | N | 62,14 | 54,06 | 55,14 | 68,12 | ||||
57536 | 283640202 | MYFENAX, F.C.TAB 500MG/TAB, BTX150 BLISTER (PVC/PVDC/ALU) | 644 | TEVA PHARMA BV | N | 182,50 | 158,78 | 161,96 | 200,09 | ||||
42383 | 284830101 | MYFETIL CAPS 250MG/CAP BTx100(BLISTERS 10x10) | 331 | SPECIFAR ABEE | N | 70,87 | 61,66 | 62,89 | 77,69 | ||||
42250 | 284830201 | MYFETIL FC.TAB 500 MG/TAB BTx 50 TABS | 331 | SPECIFAR AΒΕE | N | 62,14 | 54,06 | 55,14 | 68,12 | ||||
57249 | 294930101 | MYCOFEN/NEXUS CAPS 250MG/CAP BTx100(Blisters) | 536 | NEXUS MEDICALS A.E. | N | 76,82 | 66,83 | 68,17 | 84,22 | ||||
52946 | 232710301 | CAMPTO CS.SOL.INF 20MG/ML BTx1VIALx2ML (GLASS BOTTLE) | 295 | PFIZER HELLAS ΑΕ | N | 40,48 | 35,22 | 35,92 | 44,38 | ||||
52945 | 232710302 | CAMPTO CS.SOL.INF 20MG/ML BTx1VIALx5ML (GLASS BOTTLE) | 295 | PFIZER HELLAS ΑΕ | N | 100,75 | 87,65 | 89,40 | 110,44 | ||||
56373 | 232710303 | CAMPTO CS.SOL.INF. 20MG/ML BTx1 VIALx 5ML (PP BOTTLE) | 295 | PFIZER HELLAS ΑΕ | N | 100,75 | 87,65 | 89,40 | 110,44 | ||||
56371 | 232710304 | CAMPTO CS.SOL.INF. 20MG/ML BTx1 VIALx 15ML (PP BOTTLE) | 295 | PFIZER HELLAS ΑΕ | N | 302,26 | 262,97 | 268,23 | 331,37 | ||||
56372 | 232710305 | CAMPTO CS.SOL.INF. 20MG/ML BTx1 VIALx 2ML (PP BOTTLE) | 295 | PFIZER HELLAS ΑΕ | N | 40,48 | 35,22 | 35,92 | 44,38 | ||||
56492 | 275810101 | IRINOTECAN/TEVA CS.SOL.INF 20MG/ML BTx1 VIALx2ML | 644 | TEVA PHARMA B.V. | N | 34,41 | 29,94 | 30,54 | 37,73 | ||||
56494 | 275810102 | IRINOTECAN/TEVA CS.SOL.INF 20MG/ML BTx5 VIALSx2ML | 644 | TEVA PHARMA B.V. | N | 172,04 | 149,67 | 152,66 | 188,60 | ||||
56493 | 275810103 | IRINOTECAN/TEVA CS.SOL.INF 20MG/ML BTx1 VIALx5ML | 644 | TEVA PHARMA B.V. | N | 85,64 | 74,51 | 76,00 | 93,89 | ||||
56495 | 275810104 | IRINOTECAN/TEVA CS.SOL.INF 20MG/ML BTx5 VIALSx5ML | 644 | TEVA PHARMA B.V. | N | 428,19 | 372,53 | 379,98 | 469,43 | ||||
56739 | 280230101 | IRINOTECAN/GENERICS CS.SOL.INF 20MG/ML BTx1 VIALx2ML | 351 | GENERICS PHAR.HELLAS Ε | N | 34,41 | 29,94 | 30,54 | 37,73 | ||||
56740 | 280230104 | IRINOTECAN/GENERICS CS.SOL.INF 20MG/ML BTx1 VIALx5ML | 351 | GENERICS PHAR.HELLAS Ε | N | 85,64 | 74,51 | 76,00 | 93,89 | ||||
15144 | 280230107 | IRINOTECAN/ GENERICS, CS.SOL.INF 20MG/ML, BTx15ML AMBER GLAS | 351 | GENERICS PHARMA HELL | N | 322,04 | 280,17 | 285,77 | 353,04 | ||||
15145 | 280230108 | IRINOTECAN/ GENERICS, CS.SOL.INF 20MG/ML, BTx25ML AMBER GLAS | 351 | GENERICS PHARMA HELL | N | 472,34 | 410,94 | 419,16 | 517,83 | ||||
42272 | 281540101 | BIOTECAN CS.SOL.INF 20MG/1ML BTx1VIAL x 2ML | 223 | MEDICUS ΑΕ | N | 34,41 | 29,94 | 30,54 | 37,73 | ||||
42273 | 281540102 | BIOTECAN CS.SOL.INF 20MG/1ML BTx1VIAL x 5ML | 223 | MEDICUS ΑΕ | N | 85,64 | 74,51 | 76,00 | 93,89 | ||||
42288 | 281540103 | BIOTECAN CS.SOL.INF. 20MG/1ML X1VIAL X 25ML | 223 | MEDICUS ΑΕ | N | 376,83 | 327,84 | 334,40 | 413,12 | ||||
42215 | 283400101 | SANTACIL CS.SOL INF 20MG/ML BTx1VIALx2MLx40MG | 457 | SANTA PHARMA AE | N | 34,41 | 29,94 | 30,54 | 37,73 | ||||
42216 | 283400102 | SANTACIL CS.SOL INF 20MG/ML BTx1VIALx5ΜLx100MG | 457 | SANTA PHARMA AE | N | 85,64 | 74,51 | 76,00 | 93,89 | ||||
42524 | 283400103 | SANTACIL, CS.SOL.INF. 20MG/ML, BT x 10 VIALS x 2ML x 40MG |
457 | SANTA PHARMA AE | N | 429,43 | 373,60 | 381,07 | 470,77 | ||||
42525 | 283400104 | SANTACIL, CS.SOL.INF. 20MG/ML, BT x 10 VIALS x 5ML x 100MG |
457 | SANTA PHARMA AE | N | 1073,45 | 933,90 | 952,58 | 1176,82 | ||||
15003 | 284130101 | IRITEC C/S SOL.IN 40MG/2ML BTx1VIAL | 040 | ΒΙΑΝΕΞ ΑΕ | N | 47,71 | 41,51 | 42,34 | 52,31 | ||||
15002 | 284130201 | IRITEC C/S SOL.IN 100MG/5ML BTx1VIAL | 040 | ΒΙΑΝΕΞ ΑΕ | N | 119,27 | 103,76 | 105,84 | 130,75 | ||||
42379 | 286220101 | MIZANTRONE CS.SOL.INF 20MG/ML BT x 1VIAL x 2ML | 055 | VOCATE AE | N | 42,95 | 37,37 | 38,12 | 47,09 | ||||
42380 | 286220102 | MIZANTRONE CS.SOL.INF 20MG/ML BT x 1VIAL x 5ML | 055 | VOCATE AE | N | 107,35 | 93,39 | 95,26 | 117,68 | ||||
42378 | 286220103 | MIZANTRONE CS.SOL.INF 20MG/ML BT x 1VIAL x 15ML | 055 | VOCATE AE | N | 322,04 | 280,17 | 285,77 | 353,04 | ||||
42406 | 286340101 | VINTECAN CS.SOL.INF 20MG/ML BTx1 (VIALx2ML)AMBEM GLASS | 589 | AURORA PHARMACEUTIC | N | 42,95 | 37,37 | 38,12 | 47,09 | ||||
42407 | 286340102 | VINTECAN CS.SOL.INF 20MG/ML BTx1 (VIALx5ML)AMBEM GLASS | 589 | AURORA PHARMACEUTIC | N | 107,35 | 93,39 | 95,26 | 117,68 | ||||
42405 | 286340103 | VINTECAN CS.SOL.INF 20MG/ML BTx1 (VIALx15ML)AMBEM GLASS | 589 | AURORA PHARMACEUTIC | N | 322,04 | 280,17 | 285,77 | 353,04 | ||||
53056 | 230540101 | HYCAMTIN DR.PD.INJ 5VIALx4MG/5ML IV | 411 | GLAXO SMITHKLINΕ AEBE | N | 1285,10 | 1118,04 | 1140,40 | 1408,85 | ||||
53055 | 230540103 | HYCAMTIN DR.PD.INJ 1VIALx4MG/5ML | 411 | GLAXO SMITHKLINΕ AEBE | N | 161,91 | 140,86 | 143,68 | 177,50 | ||||
56152 | 230540301 | HYCAMTIN CAPS 0,25MG/CAP BTx10 σε BLIST (PVC/PCTFE/ALU) | 488 | SMITHKLINE BEECHAM PL | N | 101,19 | 88,04 | 89,80 | 110,94 | ||||
56153 | 230540401 | HYCAMTIN CAPS 1MG/CAP BTx10 σε BLIST (PVC/PCTFE/ALU) | 488 | SMITHKLINE BEECHAM PL | N | 404,79 | 352,17 | 359,21 | 443,77 | ||||
57086 | 292230202 | TOPOTECAN/TEVA Πυκνό διάλυμα για παρασκευή διαλύματος προς | 644 | TEVA PHARMA B.V. | N | 1092,34 | 950,34 | 969,35 | 1197,53 | ||||
57746 | 295070102 | TOPOTECAN HOSPIRA, C/S.SOL.IN 4MG/4ML, 5 VIALS x 4ML | 654 | HOSPIRA UK LTD | N | 699,65 | 608,70 | 620,87 | 767,02 | ||||
53105 | 225180101 | MUPHORAN DR.PD.INJ 1VIALx208MG+1AMPx4ML SOLV | 324 | SERVIER HELLAS ΕΠΕ | N | 441,83 | 384,39 | 392,08 | 484,38 | ||||
53190 | 228120101 | RILUTEK F.C.TABL 56x50MG | 316 | AVENTIS PHARMA ΑΒΕE | N | 210,23 | 182,90 | 186,56 | 230,48 | ||||
53215 | 224670101 | SOMATULINE PS.INJ.SUS. 1VIALx30MG (40MG)+1AMPx2ML SOLV+1ΣΥ | 136 | IPSEN EΠE | N | 382,84 | 333,07 | 339,73 | 419,70 | ||||
54932 | 224670301 | SOMATULINE AUTO GEL INJ.SOL 1 PF SYRx60MG | 136 | IPSEN EΠE | N | 678,39 | 590,20 | 602,00 | 743,71 | ||||
54933 | 224670401 | SOMATULINE AUTO GEL INJ.SOL 1 PF SYRx90MG | 136 | IPSEN EΠE | N | 904,66 | 787,05 | 802,79 | 991,77 | ||||
54931 | 224670501 | SOMATULINE AUTO GEL INJ.SOL 1 PF SYRx120MG | 136 | IPSEN EΠE | N | 1066,97 | 928,26 | 946,83 | 1169,71 | ||||
53282 | 233770101 | BENEFIX PS.INJ.SOL 1VIALx250IU/5ML+1VIALx5ML SOLV ANA IU | 295 | PFIZER HELLAS ΑΕ | N | 0,79 | 0,69 | 0,70 | 0,86 | ||||
53283 | 233770201 | BENEFIX PS.INJ.SOL 1VIALx500IU/5ML+1VIALx5ML SOLV ANA IU | 295 | PFIZER HELLAS ΑΕ | N | 0,79 | 0,69 | 0,70 | 0,86 | ||||
55864 | 233770202 | BENEFIX PS.INJ.SOL.500IU/ 1VIAL BTx 1VIAL + 1PF.SYRx5ML SOLV + ΣΕ | 295 | PFIZER HELLAS ΑΕ | N | 343,96 | 299,25 | 305,24 | 377,09 | ||||
53284 | 233770301 | BENEFIX PS.INJ.SOL 1VIALx1000IU/10ML+1VIALx10ML SOLV ANA IU | 295 | PFIZER HELLAS ΑΕ | N | 0,79 | 0,69 | 0,70 | 0,86 | ||||
55863 | 233770302 | BENEFIX PS.INJ.SOL.1000IU/ 1VIAL BTx 1VIAL +1PF.SYRx5ML SOLV + ΣΕ | 295 | PFIZER HELLAS ΑΕ | N | 676,32 | 588,40 | 600,17 | 741,45 | ||||
56463 | 233770401 | BENEFIX PS.INJ.SOL.2000IU/ 1VIAL BTx1VIAL+1PF.SYRx5ML SOLV+ΣΕΤ | 489 | WYETH EUROPA LTD, UK | N | 1352,15 | 1176,37 | 1199,90 | 1482,36 | ||||
53565 | 238840101 | SIMULECT PS.INJ.SOL 1VIALx20MG+1SYR SOLV | 321 | NOVARTIS HELLAS AEΒΕ | N | 986,90 | 858,60 | 875,77 | 1081,93 | ||||
53290 | 234680101 | ANZEMET F.C.TABL 3x50MG | 518 | SANOFI-AVENTIS AEBE | N | 7,95 | 6,92 | 7,06 | 8,72 | ||||
53289 | 234680201 | ANZEMET F.C.TABL 3x200MG | 518 | SANOFI-AVENTIS AEBE | N | 28,53 | 24,82 | 25,32 | 31,28 | ||||
53292 | 234680601 | ANZEMET INJ SOL BT 1AMPx100MG/5ML | 518 | SANOFI-AVENTIS AEBE | N | 16,26 | 14,15 | 14,43 | 17,83 | ||||
53539 | 228550101 | RAPILYSIN LY.PD.INJ 10IU/VIAL 2VIALx1.16G+2PF.SYRx10ML SOLV + AP | 605 | ACTAVIS GROUP PTC EHF | N | 803,34 | 698,91 | 712,89 | 880,70 | ||||
53464 | 235640101 | MABTHERA CON.SOL INF IV 2VIALx100MG/10ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 487,17 | 423,84 | 432,32 | 534,09 | ||||
53463 | 235640201 | MABTHERA CON.SOL INF IV 1VIALx500MG/50ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 1224,76 | 1065,54 | 1086,85 | 1342,69 | ||||
56191 | 270460101 | REVATIO F.C. TABL 20MG/TAB BTx90 | 470 | PFIZER LTD, UK | N | 456,15 | 396,85 | 404,79 | 500,08 | ||||
53576 | 241140101 | TEMODAL CAPS 5x5MG | 476 | SP.EUROPE | N | 14,45 | 12,57 | 12,82 | 15,84 | ||||
53572 | 241140102 | TEMODAL CAPS 20x5MG | 476 | SP.EUROPE | N | 57,79 | 50,28 | 51,29 | 63,36 | ||||
57065 | 241140103 | TEMODAL CAP 5MG/CAP SACHET (PET/ALU/PET)x5 | 476 | SP.EUROPE | N | 17,99 | 15,65 | 15,96 | 19,72 | ||||
57712 | 241140104 | TEMODAL, CAP 5MG/CAP, SACHET(PET/ALU/PET) x 20 | 476 | SP EUROPE | N | 66,65 | 57,99 | 59,15 | 73,07 | ||||
53574 | 241140201 | TEMODAL CAPS 5x20MG | 476 | SP.EUROPE | N | 57,79 | 50,28 | 51,29 | 63,36 | ||||
53571 | 241140202 | TEMODAL CAPS 20x20MG | 476 | SP.EUROPE | N | 231,16 | 201,11 | 205,13 | 253,42 | ||||
57063 | 241140203 | TEMODAL CAP 20MG/CAP BTx 5 σε ατομικούς φακελλίσκους | 476 | SP.EUROPE | N | 67,72 | 58,92 | 60,10 | 74,25 | ||||
57711 | 241140204 | TEMODAL, CAP 20MG/CAP, SACHET(PET/ALU/PET) x 20 | 476 | SP EUROPE | N | 250,93 | 218,31 | 222,68 | 275,10 | ||||
53573 | 241140301 | TEMODAL CAPS 5x100MG | 476 | SP.EUROPE | N | 287,66 | 250,26 | 255,27 | 315,36 | ||||
57060 | 241140303 | TEMODAL CAP 100MG/CAP BTx 5 σε ατομικούς φακελλίσκους | 476 | SP.EUROPE | N | 335,84 | 292,18 | 298,02 | 368,17 | ||||
53575 | 241140401 | TEMODAL CAPS 5x250MG | 476 | SP.EUROPE | N | 714,41 | 621,54 | 633,97 | 783,21 | ||||
57064 | 241140403 | TEMODAL CAP 250MG/CAP BTx 5 σε ατομικούς φακελλίσκους | 476 | SP.EUROPE | N | 847,17 | 737,04 | 751,78 | 928,75 | ||||
55921 | 241140501 | TEMODAL HARD CAPS 140MG/CAP BOTTLEx5 CAPS | 476 | SP.EUROPE | N | 398,78 | 346,94 | 353,88 | 437,18 | ||||
55920 | 241140502 | TEMODAL HARD CAPS 140MG/CAP BOTTLEx20 CAPS | 476 | SP.EUROPE | N | 1433,55 | 1247,19 | 1272,13 | 1571,59 | ||||
57061 | 241140503 | TEMODAL CAP 140MG/CAP BTx 5 σε ατομικούς φακελλίσκους | 476 | SP.EUROPE | N | 494,20 | 429,95 | 438,55 | 541,78 | ||||
57710 | 241140504 | TEMODAL, CAP 140MG/CAP, SACHET(PET/ALU/PET) x 20 | 476 | SP EUROPE | N | 1831,14 | 1593,09 | 1624,95 | 2007,46 | ||||
55922 | 241140601 | TEMODAL HARD CAPS 180MG/CAP BOTTLEx5 CAPS | 476 | SP.EUROPE | N | 509,70 | 443,44 | 452,31 | 558,78 | ||||
57062 | 241140603 | TEMODAL CAP 180MG/CAP BTx 5 σε ατομικούς φακελλίσκους | 476 | SP.EUROPE | N | 632,57 | 550,34 | 561,35 | 693,49 | ||||
56589 | 241140701 | TEMODAL PD.SOL.INF 2,5MG/ML BTx1BOTTLE | 476 | SP.EUROPE | N | 295,02 | 256,67 | 261,80 | 323,43 | ||||
57077 | 293830101 | TEMOZOLOMIDE TEVA 5 mg hard capsules, BT x 5 | 644 | TEVA PHARMA B.V. | N | 12,28 | 10,68 | 10,89 | 13,45 | ||||
57076 | 293830102 | TEMOZOLOMIDE TEVA 5 mg hard capsules, BT x 20 | 644 | TEVA PHARMA B.V. | N | 49,12 | 42,73 | 43,58 | 53,84 | ||||
57073 | 293830201 | TEMOZOLOMIDE TEVA 20 mg hard capsules, BT x 5 | 644 | TEVA PHARMA B.V. | N | 49,12 | 42,73 | 43,58 | 53,84 | ||||
57072 | 293830202 | TEMOZOLOMIDE TEVA 20mg hard capsules, BT x 20 | 644 | TEVA PHARMA B.V. | N | 196,49 | 170,95 | 174,37 | 215,42 | ||||
57067 | 293830301 | TEMOZOLOMIDE TEVA 100 mg hard capsules, BT x 5 | 644 | TEVA PHARMA B.V. | N | 244,51 | 212,72 | 216,97 | 268,04 | ||||
57066 | 293830302 | TEMOZOLOMIDE TEVA 100 mg hard capsules, BT x 20 | 644 | TEVA PHARMA B.V. | N | 860,68 | 748,79 | 763,77 | 943,56 | ||||
57069 | 293830401 | TEMOZOLOMIDE TEVA 140 mg hard capsules, BT x 5 | 644 | TEVA PHARMA B.V. | N | 338,96 | 294,90 | 300,80 | 371,61 | ||||
57068 | 293830402 | TEMOZOLOMIDE TEVA 140 mg hard capsules, BT x 20 | 644 | TEVA PHARMA B.V. | N | 1218,52 | 1060,11 | 1081,31 | 1335,85 | ||||
57071 | 293830501 | TEMOZOLOMIDE TEVA 180 mg hard capsules, BT x 5 | 644 | TEVA PHARMA B.V. | N | 433,25 | 376,93 | 384,47 | 474,97 | ||||
57070 | 293830502 | TEMOZOLOMIDE TEVA 180 mg hard capsules, BT x 20 | 644 | TEVA PHARMA B.V. | N | 1525,02 | 1326,77 | 1353,31 | 1671,88 | ||||
57075 | 293830601 | TEMOZOLOMIDE TEVA 250 mg hard capsules, BT x 5 | 644 | TEVA PHARMA B.V. | N | 607,25 | 528,31 | 538,88 | 665,73 | ||||
57074 | 293830602 | TEMOZOLOMIDE TEVA 250 mg hard capsules, BT x 20 | 644 | TEVA PHARMA B.V. | N | 2137,51 | 1859,63 | 1896,82 | 2343,33 | ||||
57724 | 294530101 | TEMOMEDAC CAPS 5MG/CAP BOTTLEx5 | 522 | MEDAC GESELLSCHAFT | N | 15,33 | 13,34 | 13,61 | 16,81 | ||||
57723 | 294530102 | TEMOMEDAC CAPS 5MG/CAP BOTTLEx20 | 522 | MEDAC GESELLSCHAFT | N | 57,74 | 50,23 | 51,23 | 63,29 | ||||
57720 | 294530201 | TEMOMEDAC CAPS 20MG/CAP BOTTLEx5 | 522 | MEDAC GESELLSCHAFT | N | 57,74 | 50,23 | 51,23 | 63,29 | ||||
57719 | 294530202 | TEMOMEDAC CAPS 20MG/CAP BOTTLEx20 | 522 | MEDAC GESELLSCHAFT | N | 203,27 | 176,84 | 180,38 | 222,84 | ||||
57714 | 294530301 | TEMOMEDAC CAPS 100MG/CAP BOTTLEx5 | 522 | MEDAC GESELLSCHAFT | N | 286,36 | 249,13 | 254,11 | 313,93 | ||||
57713 | 294530302 | TEMOMEDAC CAPS 100MG/CAP BOTTLEx20 | 522 | MEDAC GESELLSCHAFT | N | 1007,94 | 876,91 | 894,45 | 1105,00 | ||||
57716 | 294530401 | TEMOMEDAC CAPS 140MG/CAP BOTTLEx5 | 522 | MEDAC GESELLSCHAFT | N | 421,37 | 366,59 | 373,92 | 461,94 | ||||
57715 | 294530402 | TEMOMEDAC CAPS 140MG/CAP BOTTLEx20 | 522 | MEDAC GESELLSCHAFT | N | 1483,23 | 1290,41 | 1316,22 | 1626,06 | ||||
57718 | 294530501 | TEMOMEDAC CAPS 180MG/CAP BOTTLEx5 | 522 | MEDAC GESELLSCHAFT | N | 539,35 | 469,23 | 478,61 | 591,27 | ||||
57717 | 294530502 | TEMOMEDAC CAPS 180MG/CAP BOTTLEx20 | 522 | MEDAC GESELLSCHAFT | N | 1898,52 | 1651,71 | 1684,74 | 2081,33 | ||||
57722 | 294530601 | TEMOMEDAC CAPS 250MG/CAP BOTTLEx5 | 522 | MEDAC GESELLSCHAFT | N | 722,32 | 628,42 | 640,99 | 791,88 | ||||
57721 | 294530602 | TEMOMEDAC CAPS 250MG/CAP BOTTLEx20 | 522 | MEDAC GESELLSCHAFT | N | 2542,58 | 2212,04 | 2256,28 | 2787,41 | ||||
53470 | 220170102 | MEGALOTECT SOL IV INF 50U/ML 1AMPx10ML | 212 | BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. | N | 128,26 | 111,59 | 113,82 | 140,61 | ||||
53471 | 220170103 | MEGALOTECT SOL IV INF 50U/ML 1AMPx20ML | 212 | BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. | N | 223,39 | 194,35 | 198,24 | 244,91 | ||||
53469 | 220170104 | MEGALOTECT SOL IV INF 50U/ML 1 ΓΥΑΛΙΝΗ ΦΙΑΛΗ ΕΚΧΥΣΗΣx50ML | 212 | BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. | N | 638,84 | 555,79 | 566,91 | 700,36 | ||||
41111 | 239320101 | PROGRAF CAPS 30(BLIST 3x10 SACHETS AL)x1MG | 440 | ASTELLAS PHARM/CALS A | N | 49,52 | 43,08 | 43,94 | 54,28 | ||||
41112 | 239320201 | PROGRAF CAPS 30(BLIST 3x10 SACHETS AL)x5MG | 440 | ASTELLAS PHARM/CALS A | N | 236,10 | 205,41 | 209,52 | 258,84 | ||||
53672 | 239320301 | PROGRAF CS.SOL.INF 10AMPx5MG/1ML | 440 | ASTELLAS PHARM/CALS A | N | 381,20 | 331,64 | 338,27 | 417,90 | ||||
41353 | 239320401 | PROGRAF CAPS BT 30x0,5MG | 440 | ASTELLAS PHARM/CALS A | N | 26,56 | 23,11 | 23,57 | 29,12 | ||||
55759 | 278140101 | ADVAGRAF PR. CAP 0,5MG/CAP BTx30 (BLISTERS (PVC/PVDC/ALU) | 575 | ASTELLAS PHARMA GMB | N | 27,67 | 24,07 | 24,55 | 30,33 | ||||
55760 | 278140201 | ADVAGRAF PR. CAP 1MG/CAP BTx30 (BLISTERS (PVC/PVDC/ALU) | 575 | ASTELLAS PHARMA GMB | N | 51,34 | 44,67 | 45,56 | 56,28 | ||||
55761 | 278140301 | ADVAGRAF PR. CAP 5MG/CAP BTx30 (BLISTERS (PVC/PVDC/ALU) | 575 | ASTELLAS PHARMA GMB | N | 232,43 | 202,21 | 206,25 | 254,80 | ||||
57309 | 278140401 | ADVAGRAF, PR.CAP. 3MG/CAP, BT x 30 (3 x 10 BLIST) |
440 | ASTELLAS PHARMACEUTI | N | 150,70 | 131,11 | 133,73 | 165,21 | ||||
53739 | 245150101 | REBETOL CAPS 84x200MG | 476 | SP.EUROPE | N | 236,20 | 205,49 | 209,60 | 258,94 | ||||
53737 | 245150102 | REBETOL CAPS 140x200MG | 476 | SP.EUROPE | N | 393,67 | 342,49 | 349,34 | 431,57 | ||||
53738 | 245150103 | REBETOL CAPS 168x200MG | 476 | SP.EUROPE | N | 472,41 | 411,00 | 419,22 | 517,90 | ||||
55573 | 245150201 | REBETOL ORAL.SOL. 40MG/ML FLx100ML | 476 | SP.EUROPE | N | 54,94 | 47,80 | 48,76 | 60,24 | ||||
54795 | 257320101 | COPEGUS F.C.TABL 28x200MG | 315 | ROCHE EΛΛAΣ ΑΕ | N | 75,30 | 65,51 | 66,82 | 82,55 | ||||
54796 | 257320102 | COPEGUS F.C.TABL 42x200MG | 315 | ROCHE EΛΛAΣ ΑΕ | N | 110,66 | 96,27 | 98,20 | 121,32 | ||||
54793 | 257320103 | COPEGUS F.C.TABL 112x200MG | 315 | ROCHE EΛΛAΣ ΑΕ | N | 278,54 | 242,33 | 247,18 | 305,37 | ||||
54794 | 257320104 | COPEGUS F.C.TABL 168x200MG | 315 | ROCHE EΛΛAΣ ΑΕ | N | 499,69 | 434,73 | 443,42 | 547,80 | ||||
56051 | 257320202 | COPEGUS FC. TAB 400MG/TAB BTx1 BOTTLE x 56 | 315 | ROCHE EΛΛAΣ ΑΕ | N | 333,43 | 290,08 | 295,88 | 365,53 | ||||
57673 | 291890106 | RIBAVIRIN/TEVA FC.TAB 200MG/TAB BTx112 (BLISTERS PVC/PE/PVAc) | 644 | TEVA PHARMA B.V | N | 250,69 | 218,10 | 222,46 | 274,83 | ||||
57032 | 291890108 | RIBAVIRIN/TEVA PHARMA BV FC.TAB 200 MG/TAB, BT x 168 (BLISTERS | 644 | TEVA PHARMA B.V. | N | 424,74 | 369,52 | 376,91 | 465,63 | ||||
57030 | 291900104 | RIBAVIRIN/TEVA CAPS 200 MG/CAP, BT x 168 (BLISTERS PVC/PE/PVdC | 644 | TEVA PHARMA B.V. | N | 401,55 | 349,35 | 356,34 | 440,22 | ||||
53821 | 247490101 | FERRIPROX F.C.TABL 100x500MG | 079 | DEMO AE | N | 166,82 | 145,13 | 148,03 | 182,88 | ||||
56151 | 247490202 | FERRIPROX OR.SOL. 500MG/5ML (100MG/ML) PLASTIC BOTTLEx500ML | 616 | APOTEX EUROPE B.V. | N | 174,99 | 152,24 | 155,28 | 191,83 | ||||
53889 | 243750201 | SYNAGIS PS.INJ.SOL 1FLx100MG+SOLV 1ML | 512 | ABBOTT LABOR. LTD | N | 815,40 | 709,40 | 723,59 | 893,92 | ||||
53882 | 248450101 | REMICADE PD.SOL.INF 1FLx100MG/20ML | 109 | SCHERING PLOUGH AΦBE | N | 528,72 | 459,99 | 469,19 | 579,64 | ||||
54046 | 245740101 | PEGINTRON PS INJ SOL 1VIALx50MCG+SOLV | 476 | SP.EUROPE | N | 67,78 | 58,97 | 60,15 | 74,31 | ||||
54328 | 245740201 | PEGINTRON PS INJ SOL 1 VIALx80MCG+SOLV 0,5ML | 476 | SP.EUROPE | N | 105,47 | 91,76 | 93,60 | 115,63 | ||||
54325 | 245740301 | PEGINTRON PS INJ SOL 1 VIALx100MCG+SOLV 0,5ML | 476 | SP.EUROPE | N | 165,80 | 144,25 | 147,14 | 181,78 | ||||
54326 | 245740401 | PEGINTRON PS INJ SOL 1 VIALx120MCG+SOLV 0,5ML | 476 | SP.EUROPE | N | 158,33 | 137,75 | 140,51 | 173,59 | ||||
54327 | 245740501 | PEGINTRON PS INJ SOL 1 VIALx150MCG+SOLV 0,5ML | 476 | SP.EUROPE | N | 240,10 | 208,89 | 213,07 | 263,23 | ||||
54753 | 245740601 | PEGINTRON PS INJ PREFILL PEN 50MCG | 476 | SP.EUROPE | N | 82,92 | 72,14 | 73,58 | 90,90 | ||||
54754 | 245740701 | PEGINTRON PS INJ PREFILL PEN 80MCG | 476 | SP.EUROPE | N | 132,10 | 114,93 | 117,23 | 144,83 | ||||
54750 | 245740801 | PEGINTRON PS INJ PREFILL PEN 100MCG | 476 | SP.EUROPE | N | 165,80 | 144,25 | 147,14 | 181,78 | ||||
54751 | 245740901 | PEGINTRON PS INJ PREFILL PEN 120MCG | 476 | SP.EUROPE | N | 198,93 | 173,07 | 176,53 | 218,09 | ||||
54752 | 245741001 | PEGINTRON PS INJ PREFILL PEN 150MCG | 476 | SP.EUROPE | N | 253,52 | 220,56 | 224,97 | 277,93 | ||||
54647 | 251730301 | PEGASΥS INJ.SOL.PF.SYR 1x135MCG/0,5ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 144,83 | 126,00 | 128,52 | 158,77 | ||||
54649 | 251730302 | PEGASΥS INJ.SOL.PF.SYR 4x135MCG/0,5ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 568,33 | 494,45 | 504,34 | 623,06 | ||||
54648 | 251730401 | PEGASΥS INJ.SOL.PF.SYR 1x180MCG/0,5ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 167,83 | 146,01 | 148,93 | 183,99 | ||||
54650 | 251730402 | PEGASΥS INJ.SOL.PF.SYR 4x180MCG/0,5ML | 315 | ROCHE EΛΛAΣ ΑΕ | N | 658,74 | 573,10 | 584,56 | 722,17 | ||||
53937 | 244600101 | ENBREL PS INJ 4 VIALSx25MG+4 SYR | 295 | PFIZER HELLAS ΑΕ | N | 364,74 | 317,32 | 323,67 | 399,86 | ||||
54885 | 244600102 | ENBREL PS.INJ 4VIALSx25MG+ 4P.F SYR+8NEEDLES | 295 | PFIZER HELLAS ΑΕ | N | 470,15 | 409,03 | 417,21 | 515,42 | ||||
55217 | 244600602 | ENBREL PS. INJ.SOL 50MG VIALx 4 + 4 PF + 4 ΒΕΛ. + 4 ΠΡΟΣΑΡΜΟΓΕΣ + | 295 | PFIZER HELLAS ΑΕ | N | 755,38 | 657,18 | 670,32 | 828,11 | ||||
55695 | 244600701 | ENBREL PS.INJ.SOL 25MG/VIAL-ΓΙΑ ΠΑΙΔ. ΧΡΗΣΗ BTx4VIALS+4PF.SYRX | 295 | PFIZER HELLAS ΑΕ | N | 494,24 | 429,99 | 438,59 | 541,83 | ||||
55693 | 244600801 | ENBREL NJ.SOL 25MG/0,5ML PF.SYR BTx4 PF.SYRx0,5ML + 8 τολύπια | 295 | PFIZER HELLAS ΑΕ | N | 503,99 | 438,47 | 447,24 | 552,52 | ||||
55694 | 244600902 | ENBREL NJ.SOL 50MG/1ML PF.SYR BTx4 PF.SYRx1ML + 8 τολύπια | 295 | PFIZER HELLAS ΑΕ | N | 988,84 | 860,29 | 877,50 | 1084,06 | ||||
56617 | 244601002 | ENBREL INJ.SOL.PF.PEN 50MG/ML BTx4 x 1ML + 8 τολύπια | 489 | WYETH EUROPA LTD, UK | N | 949,54 | 826,10 | 842,62 | 1040,97 | ||||
54084 | 246890101 | VISUDINE PS SO INF 1 VIAL X15MG/10ML | 321 | NOVARTIS HELLAS AEΒΕ | N | 1067,95 | 929,12 | 947,70 | 1170,79 | ||||
53953 | 245730101 | HERCEPTIN PS CO INF 1 VIALx150MG | 315 | ROCHE EΛΛAΣ ΑΕ | N | 565,64 | 492,11 | 501,95 | 620,11 | ||||
54092 | 238900101 | BEROMUN PS.SO.INF BTx 4 VIALSx1MG+4 S0LV | 214 | BOEHRINGER INGELHEIM | N | 8133,67 | 7076,29 | 7217,82 | 8916,89 | ||||
54216 | 247120101 | XELODA F.C.TAB. BT 60x150MG | 315 | ROCHE EΛΛAΣ ΑΕ | N | 45,78 | 39,83 | 40,63 | 50,19 | ||||
54215 | 247120201 | XELODA F.C.TAB. BT 120x500MG | 315 | ROCHE EΛΛAΣ ΑΕ | N | 318,90 | 277,44 | 282,99 | 349,61 | ||||
54395 | 248150201 | ZOMETA CS.SOL.INF 1VIALX4MG/5ML | 321 | NOVARTIS HELLAS AEΒΕ | N | 230,75 | 200,75 | 204,77 | 252,97 | ||||
54345 | 252080102 | RAPAMUNE ORAL SOL FL 150MLx1MG/ML | 408 | WYETH EΛΛΑΣ ΑΕΒΕ | N | 418,97 | 364,50 | 371,79 | 459,31 | ||||
54347 | 252080201 | RAPAMUNE SACHETS 30x1MG/ML | 408 | WYETH EΛΛΑΣ ΑΕΒΕ | N | 83,78 | 72,89 | 74,35 | 91,85 | ||||
54348 | 252080301 | RAPAMUNE SACHETS 30x2MG/2ML | 408 | WYETH EΛΛΑΣ ΑΕΒΕ | N | 167,59 | 145,80 | 148,72 | 183,73 | ||||
54349 | 252080401 | RAPAMUNE SACHETS 30x5MG/5ML | 408 | WYETH EΛΛΑΣ ΑΕΒΕ | N | 418,97 | 364,50 | 371,79 | 459,31 | ||||
54657 | 252080501 | RAPAMUNE F.C.TABL BT 30x1MG | 295 | PFIZER HELLAS ΑΕ | N | 112,34 | 97,74 | 99,69 | 123,16 | ||||
54404 | 248400102 | ARANESP INJ 4 PF SYRx10MCG/0,4ML | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 64,45 | 56,07 | 57,19 | 70,65 | ||||
54406 | 248400202 | ARANESP INJ 4 PF SYRx15MCG/0,375ML | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 89,79 | 78,12 | 79,68 | 98,44 | ||||
54407 | 248400302 | ARANESP INJ 4 PF SYRx20MCG/0,5ML | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 124,13 | 107,99 | 110,15 | 136,08 | ||||
57316 | 248400305 | ARANESP SOLUTION FOR INJECTION 20MCG/0,5ML PF.SYR./ BTx4PF.S | 023 | AMGEN EUROPE | N | 124,11 | 107,98 | 110,14 | 136,07 | ||||
54408 | 248400402 | ARANESP INJ 4 PF SYRx30MCG/0,3ML | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 189,44 | 164,81 | 168,11 | 207,68 | ||||
57318 | 248400405 | ARANESP SOLUTION FOR INJECTION 30MCG/0,3ML PF.SYR./ BTx4PF.S | 023 | AMGEN EUROPE | N | 189,43 | 164,80 | 168,10 | 207,67 | ||||
54409 | 248400502 | ARANESP INJ 4 PF SYRx40MCG/0,4ML | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 239,46 | 208,33 | 212,50 | 262,52 | ||||
57319 | 248400505 | ARANESP SOLUTION FOR INJECTION 40MCG/0,4ML PF.SYR./ BTx4PF.S | 023 | AMGEN EUROPE | N | 239,47 | 208,34 | 212,51 | 262,53 | ||||
54410 | 248400602 | ARANESP INJ 4 PF SYRx50MCG/0,5ML | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 299,33 | 260,42 | 265,63 | 328,16 | ||||
57321 | 248400605 | ARANESP SOLUTION FOR INJECTION 50MCG/0,5ML PF.SYR./ BTx4PF.S | 023 | AMGEN EUROPE | N | 299,33 | 260,42 | 265,63 | 328,16 | ||||
54411 | 248400702 | ARANESP INJ 4 PF SYRx60MCG/0,3ML | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 370,09 | 321,98 | 328,42 | 405,73 | ||||
57322 | 248400705 | ARANESP SOLUTION FOR INJECTION 60MCG/0,3ML PF.SYR./ BTx4PF.S | 023 | AMGEN EUROPE | N | 370,09 | 321,98 | 328,42 | 405,73 | ||||
54412 | 248400802 | ARANESP INJ 4 PF SYRx80MCG/0,4ML | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 497,14 | 432,51 | 441,16 | 545,01 | ||||
57323 | 248400805 | ARANESP SOLUTION FOR INJECTION 80MCG/0,4ML PF.SYR./ BTx4PF.S | 023 | AMGEN EUROPE | N | 497,13 | 432,50 | 441,15 | 545,00 | ||||
54403 | 248400902 | ARANESP INJ 4 PF SYRx100MCG/0,5ML | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 600,26 | 522,23 | 532,67 | 658,06 | ||||
57314 | 248400905 | ARANESP SOLUTION FOR INJECTION 100MCG/0,5ML PF.SYR./ BTx4PF. | 023 | AMGEN EUROPE | N | 600,26 | 522,23 | 532,67 | 658,06 | ||||
54405 | 248401002 | ARANESP INJ 4 PF SYRx150MCG/0,3ML | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 923,86 | 803,76 | 819,84 | 1012,83 | ||||
57315 | 248401005 | ARANESP SOLUTION FOR INJECTION 150MCG/0,3ML PF.SYR./ BTx4PF. | 023 | AMGEN EUROPE | N | 923,87 | 803,77 | 819,85 | 1012,84 | ||||
54700 | 248401101 | ARANESP INJ.SOL.1PF.SYRx300MCG/0,6ML | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 452,90 | 394,02 | 401,90 | 496,51 | ||||
57317 | 248401104 | ARANESP SOLUTION FOR INJECTION 300MCG/0,6ML PF.SYR./ BTx1PF. | 023 | AMGEN EUROPE | N | 452,90 | 394,02 | 401,90 | 496,51 | ||||
54968 | 248401601 | ARANESP INJ.SOL 1PF.SYRx500MCG/1ML | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 753,38 | 655,44 | 668,55 | 825,93 | ||||
57320 | 248401604 | ARANESP SOLUTION FOR INJECTION 500MCG/1ML PF.SYR./BTx1PF.SY | 023 | AMGEN EUROPE | N | 753,38 | 655,44 | 668,55 | 825,93 | ||||
55152 | 248401901 | ARANESP INJ.SOL. 20MCG/0,5ML PF.PEN BTx1PF.PENx0,5ML (SURE CLI | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 32,25 | 28,06 | 28,62 | 35,36 | ||||
55154 | 248402101 | ARANESP INJ.SOL. 40MCG/0,4ML PF.PEN BTx1PF.PENx0,4ML (SURE CLI | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 69,66 | 60,60 | 61,81 | 76,36 | ||||
55156 | 248402301 | ARANESP INJ.SOL. 60MCG/0,3ML PF.PEN BTx1PF.PENx0,3ML (SURE CLI | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 105,80 | 92,05 | 93,89 | 115,99 | ||||
55157 | 248402401 | ARANESP INJ.SOL. 80MCG/0,4ML PF.PEN BTx1PF.PENx0,4ML (SURE CLI | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 126,41 | 109,98 | 112,18 | 138,59 | ||||
55150 | 248402501 | ARANESP INJ.SOL. 100MCG/0,5ML PF.PEN BTx1PF.PENx0,5ML (SURE C | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 173,53 | 150,97 | 153,99 | 190,24 | ||||
55151 | 248402601 | ARANESP INJ.SOL. 150MCG/0,3ML PF.PEN BTx1PF.PENx0,3ML (SURE C | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 250,14 | 217,62 | 221,97 | 274,22 | ||||
55153 | 248402701 | ARANESP INJ.SOL. 300MCG/0,6ML PF.PEN BTx1PF.PENx0,6ML (SURE C | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 487,72 | 424,32 | 432,81 | 534,69 | ||||
55155 | 248402801 | ARANESP INJ.SOL. 500MCG/1ML PF.PEN BTx1PF.PENx1ML (SURE CLIC | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 753,38 | 655,44 | 668,55 | 825,93 | ||||
54443 | 240120101 | PENTAGLOBIN SOL.IV.INF 50MG/ML 1AMPx10ML | 212 | BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. | N | 41,90 | 36,45 | 37,18 | 45,93 | ||||
54444 | 240120102 | PENTAGLOBIN SOL.IV.INF 50MG/ML 1AMPx20ML | 212 | BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. | N | 78,86 | 68,61 | 69,98 | 86,45 | ||||
54446 | 240120103 | PENTAGLOBIN SOL.IV.INF 50MG/ML 1BOTTLEx50ML | 212 | BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. | N | 172,40 | 149,99 | 152,99 | 189,00 | ||||
54445 | 240120104 | PENTAGLOBIN SOL.IV.INF 50MG/ML 1BOTTLEx100ML | 212 | BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. | N | 341,00 | 296,67 | 302,60 | 373,83 | ||||
56161 | 269270101 | INTRATECT SOL.IV.INF 50MG/ML VIALx20ML | 212 | BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. | N | 59,20 | 51,50 | 52,53 | 64,90 | ||||
56162 | 269270102 | INTRATECT SOL.IV.INF 50MG/ML VIALx50ML | 212 | BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. | N | 147,75 | 128,54 | 131,11 | 161,97 | ||||
56159 | 269270103 | INTRATECT SOL.IV.INF 50MG/ML VIALx100ML | 212 | BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. | N | 291,62 | 253,71 | 258,78 | 319,70 | ||||
56160 | 269270104 | INTRATECT SOL.IV.INF 50MG/ML VIALx200ML | 212 | BIOTEST ΕΛΛΑΣ Μ.Ε.Π.Ε. | N | 578,37 | 503,18 | 513,24 | 634,06 | ||||
55851 | 272140101 | IG VENA SOL.IV.INF 0,05G/ML BOTTLEx20ML | 540 | KEDRION SPA LUCCA ITAL | N | 62,99 | 54,80 | 55,90 | 69,06 | ||||
55852 | 272140102 | IG VENA SOL.IV.INF 0,05G/ML BOTTLEx50ML + Σετ έγχυσης | 540 | KEDRION SPA LUCCA ITAL | N | 157,47 | 137,00 | 139,74 | 172,63 | ||||
55853 | 272140103 | IG VENA SOL.IV.INF 0,05G/ML BOTTLEx100ML + Σετ έγχυσης | 540 | KEDRION SPA LUCCA ITAL | N | 314,94 | 274,00 | 279,48 | 345,27 | ||||
55854 | 272140104 | IG VENA SOL.IV.INF 0,05G/ML BOTTLEx200ML + Σετ έγχυσης | 540 | KEDRION SPA LUCCA ITAL | N | 629,89 | 548,00 | 558,96 | 690,54 | ||||
54438 | 249030101 | MAB CAMPATH CS.SOL.INF 3AMP 3MLx10MG/ML | 465 | GENZYME BV, NEDERLAN | N | 970,74 | 844,54 | 861,43 | 1064,21 | ||||
55715 | 249030201 | MAB CAMPATH CS.SOL.INF 30MG/ML BTx3 VIALSx1ML | 465 | GENZYME BV, NEDERLAN | N | 1070,97 | 931,74 | 950,37 | 1174,09 | ||||
54540 | 250090101 | REPLAGAL CS.SOL INF. 1VIAL 3,5MLx1MG/ML | 361 | TKT | N | 1763,40 | 1534,16 | 1564,84 | 1933,20 | ||||
55509 | 250220101 | FABRAZYME PD.INJ.SOL IV BTx1VIALx35MG/VIAL | 465 | GENZYME BV, NEDERLAN | N | 3444,84 | 2997,01 | 3056,95 | 3776,56 | ||||
56060 | 250220201 | FABRAZYME PD.INJ.SOL IV 5MG/VIAL BTx1VIAL | 465 | GENZYME BV, NEDERLAN | N | 492,11 | 428,14 | 436,70 | 539,50 | ||||
54504 | 253440204 | GLIVEC CAPS BT 120x100MG | 321 | NOVARTIS HELLAS AEΒΕ | N | 2289,68 | 1992,02 | 2031,86 | 2510,16 | ||||
55034 | 253440302 | GLIVEC F.C.TABL BT 60x100MG | 321 | NOVARTIS HELLAS AEΒΕ | N | 1197,23 | 1041,59 | 1062,42 | 1312,51 | ||||
55033 | 253440402 | GLIVEC F.C.TABL BT 30x400MG | 321 | NOVARTIS HELLAS AEΒΕ | N | 2408,26 | 2095,19 | 2137,09 | 2640,16 | ||||
54523 | 245460101 | PANRETIN GEL 0,1% TB 60G | 350 | GALENICA AE | N | 1381,71 | 1202,09 | 1226,13 | 1514,76 | ||||
54525 | 239530101 | PHOTOFRIN PD.INJ.SOL 1VIALx15MG | 350 | GALENICA AE | N | 184,60 | 160,60 | 163,81 | 202,37 | ||||
54526 | 239530201 | PHOTOFRIN PD.INJ.SOL 1VIALx75MG | 350 | GALENICA AE | N | 923,00 | 803,01 | 819,07 | 1011,88 | ||||
55197 | 252570201 | COPAXONE INJ. SOL 20MG/1ML BT 28PF. SYRx1ML | 431 | TEVA PHARMACEUTICALS | N | 644,38 | 560,61 | 571,82 | 706,43 | ||||
54554 | 252720101 | TARGRETIN CAPS BT 100x75MG | 350 | GALENICA AE | N | 1018,00 | 885,66 | 903,37 | 1116,02 | ||||
54616 | 249950103 | KINERET INJ.SOL 28PF.SYRx100MG/0,67ML | 676 | BIOVINTRUM AB | N | 817,98 | 711,64 | 725,87 | 896,74 | ||||
54678 | 253400101 | VIREAD F.C.TABL FL 30x245MG | 068 | GILEAD | N | 288,99 | 251,42 | 256,45 | 316,82 | ||||
54676 | 252130102 | TRACLEER F.C.TAB BT 56x62,5MG | 020 | ACTELION | N | 2606,15 | 2267,35 | 2312,70 | 2857,11 | ||||
54675 | 252130201 | TRACLEER F.C.TAB BT 56x125MG | 020 | ACTELION | N | 2606,15 | 2267,35 | 2312,70 | 2857,11 | ||||
54812 | 258870101 | NEULASTA INJ.SOL. BT 1PF.SYR. 0,6MLx10MG/ML | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 869,45 | 756,42 | 771,55 | 953,17 | ||||
57539 | 258870103 | NEULASTA, INJ. SOL. PF.SYR , 6MG/0,6ML(10MG/ML) BTx1PF.SYR με μ | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ | N | 869,46 | 756,43 | 771,56 | 953,19 | ||||
54803 | 247360201 | FOSCAN INJ.IV.SOL 1VIALx5MLx4MG/ML | 063 | ΓΕΝΕΣΙΣ ΦΑΡΜΑ ΑΕ | N | 4426,90 | 3851,40 | 3928,43 | 4853,18 | ||||
54815 | 253930101 | SOMAVERT PD.INJ.SO BT 30VIALSx10MG+30VIALSx8ML SOLV | 295 | PFIZER HELLAS ΑΕ | N | 2022,63 | 1759,69 | 1794,88 | 2217,39 | ||||
54816 | 253930201 | SOMAVERT PD.INJ.SO BT 30VIALSx15MG+30VIALSx8ML SOLV | 295 | PFIZER HELLAS ΑΕ | N | 3052,57 | 2655,74 | 2708,85 | 3346,51 | ||||
54817 | 253930301 | SOMAVERT PD.INJ.SO BT 30VIALSx20MG+30VIALSx8ML SOLV | 295 | PFIZER HELLAS ΑΕ | N | 4045,26 | 3519,38 | 3589,77 | 4434,80 | ||||
54957 | 253930302 | SOMAVERT PD.INJ.SO 1VIALx20MG+SOLV 8ML | 295 | PFIZER HELLAS ΑΕ | N | 139,17 | 121,08 | 123,50 | 152,57 | ||||
54893 | 259970101 | HEPSERA TABL FL 30x10MG | 068 | GILEAD | N | 405,64 | 352,91 | 359,97 | 444,71 | ||||
54902 | 260250101 | ZAVESCA HARD CAPS BT 84x100MG | 020 | ACTELION | N | 6843,46 | 5953,81 | 6072,89 | 7502,45 | ||||
54916 | 256960201 | HUMIRA SOL.INJ. 1PF SYR 40MG/0,8ML+ALCOHOL PAD | 512 | ABBOTT LABOR. LTD | N | 471,36 | 410,08 | 418,28 | 516,74 | ||||
55074 | 265480101 | VELCADE PS.INJ.SOL 1VIALx3,5MG | 061 | JANSSEN-CILAG ΑΕΒΕ | N | 1009,10 | 877,92 | 895,48 | 1106,28 | ||||
55021 | 261570102 | CERTICAN TABL BT 60x0,25MG | 321 | NOVARTIS HELLAS AEΒΕ | N | 104,72 | 91,11 | 92,93 | 114,81 | ||||
55022 | 261570202 | CERTICAN TABL BT 60x0,50MG | 321 | NOVARTIS HELLAS AEΒΕ | N | 215,31 | 187,32 | 191,07 | 236,05 | ||||
55023 | 261570302 | CERTICAN TABL BT 60x0,75MG | 321 | NOVARTIS HELLAS AEΒΕ | N | 311,02 | 270,59 | 276,00 | 340,97 | ||||
55183 | 261570402 | CERTICAN TABL BT 60x1MG (BLIST 6x10) | 321 | NOVARTIS HELLAS AEΒΕ | N | 501,84 | 436,60 | 445,33 | 550,16 | ||||
55024 | 261570602 | CERTICAN TABL. DISP BT 60x0,25MG | 321 | NOVARTIS HELLAS AEΒΕ | N | 104,72 | 91,11 | 92,93 | 114,81 | ||||
56645 | 290970101 | AFINITOR TAB 5MG/TAB BT x 30 σε BLISTERS (ALU/PA/ALU/PVC) | 517 | NOVARTIS EUROPHARM | N | 2670,36 | 2323,21 | 2369,67 | 2927,49 | ||||
56646 | 290970201 | AFINITOR TAB 10MG/TAB BT x 30 σε BLISTERS (ALU/PA/ALU/PVC) | 517 | NOVARTIS EUROPHARM | N | 3479,22 | 3026,92 | 3087,46 | 3814,25 | ||||
55086 | 266780101 | ALIMTA PD.INF. 1VIALx500MG | 566 | ELI-LILLY NED B.V. | N | 1108,00 | 963,96 | 983,24 | 1214,69 | ||||
55321 | 262810105 | MYFORTIC F.C. TABL BT 120x180MG | 321 | NOVARTIS HELLAS AEΒΕ | N | 132,69 | 115,44 | 117,75 | 145,47 | ||||
55322 | 262810204 | MYFORTIC F.C. TABL BT 120x360MG | 321 | NOVARTIS HELLAS AEΒΕ | N | 253,02 | 220,13 | 224,53 | 277,38 | ||||
55411 | 252100101 | TRISENOX CS.SOL.INF 1MG/ML BTx10AMPSx10ML | 142 | CEPHALON UK LTD | N | 3859,06 | 3357,38 | 3424,53 | 4230,66 | ||||
55448 | 267360101 | XAGRID 0.5MG (HARD CAPS) BOTTLEx100 CAPS | 490 | SHIRE PHAR/CAL CONTR. | N | 409,11 | 355,93 | 363,05 | 448,51 | ||||
55169 | 267690101 | AVASTIN CS. SOL. INF 25MG/ML BTx1VIALx4ML (100MG/4ML) | 315 | ROCHE EΛΛAΣ ΑΕ | N | 316,71 | 275,54 | 281,05 | 347,21 | ||||
55168 | 267690201 | AVASTIN CS. SOL. INF 25MG/ML BTx1VIALx16ML (400MG/16ML) | 315 | ROCHE EΛΛAΣ ΑΕ | N | 1198,97 | 1043,10 | 1063,96 | 1314,42 | ||||
56327 | 223400501 | NOVOSEVEN PS.INJ.SOL 2MG(100KIU)/VIAL BTx1VIAL + 1VIALx2,1ML S | 645 | NOVO NORDISK A/S | N | 1162,32 | 1011,22 | 1031,44 | 1274,24 | ||||
56326 | 225400401 | NOVOSEVEN PS.INJ.SOL 1MG(50KIU)/VIAL BTx1VIAL + 1VIALx1,1ML S | 645 | NOVO NORDISK A/S | N | 581,06 | 505,52 | 515,63 | 637,01 | ||||
55406 | 270010101 | TARCEVA F.C. TABS BT 30x25MG | 315 | ROCHE EΛΛAΣ ΑΕ | N | 330,32 | 287,38 | 293,13 | 362,13 | ||||
55404 | 270010201 | TARCEVA F.C. TABS BT 30x100MG | 315 | ROCHE EΛΛAΣ ΑΕ | N | 1539,74 | 1339,57 | 1366,36 | 1688,00 | ||||
55405 | 270010301 | TARCEVA F.C. TABS BT 30x150MG | 315 | ROCHE EΛΛAΣ ΑΕ | N | 1899,18 | 1652,29 | 1685,34 | 2082,07 | ||||
55400 | 265090101 | SUBCUVIA INJ.SOL. 160MG/ML BTx1VIALx5ML | 462 | BAXTER AG | N | 38,70 | 33,67 | 34,34 | 42,42 | ||||
55401 | 265090102 | SUBCUVIA INJ.SOL. 160MG/ML BTx20VIALSx5ML | 462 | BAXTER AG | N | 656,67 | 571,30 | 582,73 | 719,90 | ||||
55399 | 265090103 | SUBCUVIA INJ.SOL. 160MG/ML BTx1VIALx10ML | 462 | BAXTER AG | N | 65,67 | 57,13 | 58,27 | 71,99 | ||||
55402 | 265090104 | SUBCUVIA INJ.SOL. 160MG/ML BTx20VIALx10ML | 462 | BAXTER AG | N | 1313,32 | 1142,59 | 1165,44 | 1439,78 | ||||
55603 | 265920101 | VIVAGLOBIN INJ.SOL.16% BTx1AMPx5ML | 438 | CSL BEHRING Μ.ΕΠΕ | N | 29,67 | 25,81 | 26,33 | 32,53 | ||||
55601 | 265920102 | VIVAGLOBIN INJ.SOL.16% BTx10AMPx5ML | 438 | CSL BEHRING Μ.ΕΠΕ | N | 296,71 | 258,14 | 263,30 | 325,28 | ||||
55604 | 265920103 | VIVAGLOBIN INJ.SOL.16% BTx1VIALx10ML | 438 | CSL BEHRING Μ.ΕΠΕ | N | 57,26 | 49,82 | 50,82 | 62,78 | ||||
55602 | 265920104 | VIVAGLOBIN INJ.SOL.16% BTx10VIALSx10ML | 438 | CSL BEHRING Μ.ΕΠΕ | N | 572,61 | 498,17 | 508,13 | 627,74 | ||||
55605 | 265920105 | VIVAGLOBIN INJ.SOL.16% BTx20VIALSx10ML | 438 | CSL BEHRING Μ.ΕΠΕ | N | 1147,63 | 998,44 | 1018,41 | 1258,14 | ||||
55529 | 272050101 | KIOVIG SOL.IV.INF 100MG/ML BTx1VIALx10ML | 462 | BAXTER AG | N | 46,60 | 40,54 | 41,35 | 51,08 | ||||
55531 | 272050102 | KIOVIG SOL.IV.INF 100MG/ML BTx1VIALx25ML | 462 | BAXTER AG | N | 116,51 | 101,36 | 103,39 | 127,73 | ||||
55532 | 272050103 | KIOVIG SOL.IV.INF 100MG/ML BTx1VIALx50ML | 462 | BAXTER AG | N | 233,00 | 202,71 | 206,76 | 255,43 | ||||
55528 | 272050104 | KIOVIG SOL.IV.INF 100MG/ML BTx1VIALx100ML | 462 | BAXTER AG | N | 466,00 | 405,42 | 413,53 | 510,87 | ||||
55530 | 272050105 | KIOVIG SOL.IV.INF 100MG/ML BTx1VIALx200ML | 462 | BAXTER AG | N | 932,00 | 810,84 | 827,06 | 1021,75 | ||||
56423 | 283690101 | PRIVIGEN SOL.IV.INF 100MG/ML BTx1VIALx50ML | 660 | CSL BEHRING GMBH | N | 219,55 | 191,01 | 194,83 | 240,69 | ||||
56421 | 283690102 | PRIVIGEN SOL.IV.INF 100MG/ML BTx1VIALx100ML | 660 | CSL BEHRING GMBH | N | 439,10 | 382,02 | 389,66 | 481,39 | ||||
56422 | 283690103 | PRIVIGEN SOL.IV.INF 100MG/ML BTx1VIALx200ML | 660 | CSL BEHRING GMBH | N | 878,20 | 764,03 | 779,31 | 962,76 | ||||
57426 | 289970102 | FLEBOGAMMADIF SOL INF 50MG/ML BT 1VIALx50ML | 079 | DEMO ABEE | N | 139,49 | 121,36 | 123,79 | 152,93 | ||||
57423 | 289970103 | FLEBOGAMMADIF SOL INF 50MG/ML BT 1VIALx100ML | 079 | DEMO ABEE | N | 278,98 | 242,71 | 247,56 | 305,84 | ||||
57424 | 289970104 | FLEBOGAMMADIF SOL INF 50MG/ML BT 1VIALx200ML | 079 | DEMO ABEE | N | 557,97 | 485,43 | 495,14 | 611,70 | ||||
57425 | 289970105 | FLEBOGAMMADIF SOL INF 50MG/ML BT 1VIALx400ML | 079 | DEMO ABEE | N | 1115,92 | 970,85 | 990,27 | 1223,38 | ||||
55451 | 249920201 | XOLAIR PS.INJ.SOL. 150MG/VIAL BTx1VIAL + 1AMP + 2ML/SOLV | 517 | NOVARTIS EUROPHARM | N | 351,56 | 305,86 | 311,98 | 385,42 | ||||
57109 | 249920301 | XOLAIR INJ.SOL. 75MG/0,5ML PF SYR / BTx1 PF SYR x 0.5ML | 517 | NOVARTIS EUROPHARM | N | 190,25 | 165,52 | 168,83 | 208,57 | ||||
57304 | 249920401 | XOLAIR INJ.SOL 150MG/1,0ML BTx1PF.SYRx1,0ML | 517 | NOVARTIS EUROPHARM | N | 351,56 | 305,86 | 311,98 | 385,42 | ||||
55182 | 234950101 | CEREZYME PD.SOL.INF200U/VIAL BTx1 VIAL | 465 | GENZYME BV, NEDERLAN | N | 837,76 | 728,85 | 743,43 | 918,43 | ||||
56048 | 234950201 | CEREZYME PD.SOL. INF 400U/VIAL BTx1 VIAL | 465 | GENZYME BV, NEDERLAN | N | 1661,20 | 1445,24 | 1474,14 | 1821,15 | ||||
55302 | 270120101 | LYSODREN TABL 500MG/TAB FL (HDPE)x100 | 472 | LAB.HRA PHARMA | N | 630,40 | 548,45 | 559,42 | 691,11 | ||||
55281 | 270680101 | KEPIVANCE PD.INJ.SOL 6,25MG/VIAL BTx6VIALS | 676 | BIOVINTRUM AB | N | 4509,71 | 3923,45 | 4001,92 | 4943,97 | ||||
56639 | 281910101 | VENBIG PS.SOL.INF 50IU/ML BTx1VIALx500 IU+1 VIALx10ML SOLV+ σετ | 540 | KEDRION SPA LUCCA ITAL | N | 336,39 | 292,66 | 298,51 | 368,78 | ||||
55547 | 273490101 | NEXAVAR F.C.TAB 200MG/TAB BTx112 Blist (PP/ALU) 4x28 | 509 | BAYER HEALTH CARE AG | N | 3571,87 | 3107,53 | 3169,68 | 3915,82 | ||||
55504 | 274460101 | EXJADE DISP.TAB. 125MG/TAB BTx28 (BLIST 4x7) | 517 | NOVARTIS EUROPHARM | N | 182,82 | 159,05 | 162,23 | 200,42 | ||||
55505 | 274460201 | EXJADE DISP.TAB. 250MG/TAB BTx28 (BLIST 4x7) | 517 | NOVARTIS EUROPHARM | N | 377,75 | 328,64 | 335,21 | 414,12 | ||||
55506 | 274460301 | EXJADE DISP.TAB. 500MG/TAB BTx28 (BLIST 4x7) | 517 | NOVARTIS EUROPHARM | N | 722,32 | 628,42 | 640,99 | 791,88 | ||||
55536 | 271900101 | MACUGEN SOL.INJ. 0,3MG/PF.SYR BTx1PF.SYR 90μL +εμβολο+δακτ.στ | 470 | PFIZER LTD, UK | N | 572,78 | 498,32 | 508,29 | 627,94 | ||||
55977 | 271900102 | MACUGEN SOL.INJ. 0,3MG/PF.SYR BTx1PF.SYR 90μL + προγεμισμ.συρ. | 470 | PFIZER LTD, UK | N | 572,78 | 498,32 | 508,29 | 627,94 | ||||
55575 | 268890101 | REMODULIN SOL.INF 1MG/ML BTx1VIALx20ML | 442 | FERRER-GALENICA A.E. | N | 2765,46 | 2405,95 | 2454,07 | 3031,76 | ||||
55576 | 268890201 | REMODULIN SOL.INF 2,5MG/ML BTx1VIALx20ML | 442 | FERRER-GALENICA A.E. | N | 6302,61 | 5483,27 | 5592,94 | 6909,52 | ||||
55577 | 268890301 | REMODULIN SOL.INF 5MG/ML BTx1VIALx20ML | 442 | FERRER-GALENICA A.E. | N | 11018,52 | 9586,11 | 9777,83 | 12079,53 | ||||
55574 | 268890401 | REMODULIN SOL.INF 10MG/ML BTx1VIALx20ML | 442 | FERRER-GALENICA A.E. | N | 22029,56 | 19165,72 | 19549,03 | 24150,87 | ||||
56075 | 272340101 | MYOZYME PD.SOL.INF. 50MG/VIAL BTx1VIAL | 465 | GENZYME BV, NEDERLAN | N | 586,11 | 509,92 | 520,12 | 642,56 | ||||
55469 | 273340102 | BARACLUDE F.C.TAB 0,5MG/TAB BTx30TABS | 461 | BRISTOL MYERS PHARMA | N | 378,54 | 329,33 | 335,92 | 415,00 | ||||
55470 | 273340202 | BARACLUDE F.C.TAB 1MG/TAB BTx30TABS | 461 | BRISTOL MYERS PHARMA | N | 413,43 | 359,68 | 366,87 | 453,23 | ||||
55658 | 273590101 | SUTENT CAPS 12,5MG/CAP BOTTLEx30CAPS | 470 | PFIZER LTD, UK | N | 1134,47 | 986,99 | 1006,73 | 1243,71 | ||||
55659 | 273590201 | SUTENT CAPS 25MG/CAP BOTTLEx30CAPS | 470 | PFIZER LTD, UK | N | 2258,70 | 1965,07 | 2004,37 | 2476,20 | ||||
55660 | 273590301 | SUTENT CAPS 50MG/CAP BOTTLEx30CAPS | 470 | PFIZER LTD, UK | N | 4537,09 | 3947,27 | 4026,22 | 4973,99 | ||||
55646 | 275000101 | SAVENE PCS.SOL.INF 500MG/VIAL (20MG/ML) BTx10 VIALS+3 ΣΑΚΟΙ X | 527 | TOPO TARGET A/S | N | 10085,08 | 8774,02 | 8949,50 | 11056,21 | ||||
55653 | 275590101 | SPRYCEL F.C. TABS 60x20MG (BOTTLE) | 461 | BRISTOL MYERS PHARMA | N | 1845,44 | 1605,53 | 1637,64 | 2023,14 | ||||
55652 | 275590103 | SPRYCEL F.C. TABS 60x20MG (BLISTER) | 461 | BRISTOL MYERS PHARMA | N | 1845,44 | 1605,53 | 1637,64 | 2023,14 | ||||
55655 | 275590201 | SPRYCEL F.C. TABS 60x50MG (BOTTLE) | 461 | BRISTOL MYERS PHARMA | N | 3470,15 | 3019,03 | 3079,41 | 3804,30 | ||||
55654 | 275590203 | SPRYCEL F.C. TABS 60x50MG (BLISTER) | 461 | BRISTOL MYERS PHARMA | N | 3470,15 | 3019,03 | 3079,41 | 3804,30 | ||||
55657 | 275590301 | SPRYCEL F.C. TABS 60x70MG (BOTTLE) | 461 | BRISTOL MYERS PHARMA | N | 3470,15 | 3019,03 | 3079,41 | 3804,30 | ||||
55656 | 275590303 | SPRYCEL F.C. TABS 60x70MG (BLISTER) | 461 | BRISTOL MYERS PHARMA | N | 3470,15 | 3019,03 | 3079,41 | 3804,30 | ||||
55663 | 273420101 | TYSABRI CS. SOL.INF 300MG/15ML VIAL BTx1VIALx15ML | 097 | ELAN | N | 1526,23 | 1327,82 | 1354,38 | 1673,20 | ||||
55714 | 276920101 | LUCENTIS INJ.SOL 10MG/ML BTx1VIAL 2,3MG/0,23ML | 517 | NOVARTIS EUROPHARM | N | 919,08 | 799,60 | 815,59 | 1007,58 | ||||
55840 | 275580102 | THELIN F.C. TAB 100MG/TAB BTx28 BLISTERS (PVC/PE/PVDC/ALU) | 295 | PFIZER HELLAS ΑΕ | N | 2347,03 | 2041,92 | 2082,76 | 2573,04 | ||||
55875 | 277020101 | ELAPRASE CS.SOL.INF 2MG/ML 1 VIALx3ML | 555 | SHIRE HUMAN THERAPIE | N | 3004,29 | 2613,73 | 2666,00 | 3293,58 | ||||
55824 | 278010101 | ORENCIA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION | 461 | BRISTOL MYERS PHARMA | N | 336,21 | 292,50 | 298,35 | 368,58 | ||||
55787 | 269890201 | ELOXATIN C.S.SOL.INF 5MG/ML BTx1(VIALx50MGx10ML) | 518 | SANOFI-AVENTIS AEBE | N | 132,62 | 115,38 | 117,69 | 145,39 | ||||
55786 | 269890202 | ELOXATIN C.S.SOL.INF 5MG/ML BTx1(VIALx100MGx20ML) | 518 | SANOFI-AVENTIS AEBE | N | 254,38 | 221,31 | 225,74 | 278,88 | ||||
55899 | 272190101 | OXALIPLATIN/HOSPIRA PD.SOL.INF 5MG/1ML BTx1VIALx50MG | 654 | HOSPIRA UK LTD | N | 112,73 | 98,08 | 100,04 | 123,59 | ||||
55898 | 272190102 | OXALIPLATIN/HOSPIRA PD.SOL.INF 5MG/1ML BTx1VIALx100MG | 654 | HOSPIRA UK LTD | N | 216,22 | 188,11 | 191,87 | 237,04 | ||||
56515 | 272190201 | OXALIPLATIN/HOSPIRA CS.SOL.INF 5MG/ML BTx1VIALx10ML | 654 | HOSPIRA UK LTD | N | 112,73 | 98,08 | 100,04 | 123,59 | ||||
56516 | 272190202 | OXALIPLATIN/HOSPIRA CS.SOL.INF 5MG/ML BTx1VIALx20ML | 654 | HOSPIRA UK LTD | N | 216,22 | 188,11 | 191,87 | 237,04 | ||||
42023 | 272650101 | OXALIPLATIN/TEVA CS. SOL.INF 5MG/ML BTx1 VIAL 20MG/4ML | 644 | TEVA PHARMA B.V. | N | 50,50 | 43,94 | 44,82 | 55,37 | ||||
42024 | 272650102 | OXALIPLATIN/TEVA CS. SOL.INF 5MG/ML BTx1 VIAL 50MG/10ML | 644 | TEVA PHARMA B.V. | N | 112,73 | 98,08 | 100,04 | 123,59 | ||||
42022 | 272650103 | OXALIPLATIN/TEVA CS. SOL.INF 5MG/ML BTx1 VIAL 100MG/20ML | 644 | TEVA PHARMA B.V. | N | 216,22 | 188,11 | 191,87 | 237,04 | ||||
42026 | 272650201 | OXALIPLATIN/TEVA PD. SOL.INF 5MG/ML BTx1 VIALx20MG | 644 | TEVA PHARMA B.V. | N | 50,50 | 43,94 | 44,82 | 55,37 | ||||
42027 | 272650202 | OXALIPLATIN/TEVA PD. SOL.INF 5MG/ML BTx1 VIALx50MG | 644 | TEVA PHARMA B.V. | N | 112,73 | 98,08 | 100,04 | 123,59 | ||||
42025 | 272650203 | OXALIPLATIN/TEVA PD. SOL.INF 5MG/ML BTx1 VIALx100MG | 644 | TEVA PHARMA B.V. | N | 216,22 | 188,11 | 191,87 | 237,04 | ||||
56179 | 278700101 | PLAXITIN PD.SOL.INF 5MG/ML BTx1VIAL(50MG/VIAL) | 564 | EBEWE PHARMA GMBH | N | 112,73 | 98,08 | 100,04 | 123,59 | ||||
56177 | 278700102 | PLAXITIN PD.SOL.INF 5MG/ML BTx1VIAL(100MG/VIAL) | 564 | EBEWE PHARMA GMBH | N | 216,22 | 188,11 | 191,87 | 237,04 | ||||
56178 | 278700103 | PLAXITIN PD.SOL.INF 5MG/ML BTx1VIAL(150MG/VIAL) | 564 | EBEWE PHARMA GMBH | N | 286,48 | 249,24 | 254,22 | 314,06 | ||||
57261 | 278770101 | OXALIPLATIN/KABI C/S.SOL.IN 5MG/ML VIALx10MLx50MG | 706 | FRESENIUS KABI ONC. PL | N | 118,84 | 103,39 | 105,46 | 130,29 | ||||
57262 | 278770102 | OXALIPLATIN/KABI C/S.SOL.IN 5MG/ML VIALx20MLx100MG | 706 | FRESENIUS KABI ONC. PL | N | 237,69 | 206,79 | 210,93 | 260,58 | ||||
42212 | 281890101 | OXALIPROL CS.SOL.INF 5MG/1ML BTx1VIALx10ML | 293 | NOVENDIA PHARMACEU | N | 112,73 | 98,08 | 100,04 | 123,59 | ||||
42213 | 281890102 | OXALIPROL CS.SOL.INF 5MG/1ML BTx1VIALx20ML | 293 | NOVENDIA PHARMACEU | N | 216,22 | 188,11 | 191,87 | 237,04 | ||||
42214 | 281890103 | OXALIPROL CS.SOL.INF 5MG/1ML BTx1VIALx40ML | 293 | NOVENDIA PHARMACEU | N | 396,80 | 345,22 | 352,12 | 435,01 | ||||
42334 | 282370101 | OXALIPLATIN/MEDICUS CS.SOL.INF.5MG/1ML X 1VIAL X 10ML | 223 | MEDICUS ΑΕ | N | 112,73 | 98,08 | 100,04 | 123,59 | ||||
42335 | 282370102 | OXALIPLATIN/MEDICUS CS.SOL.INF.5MG/1ML X 1VIAL X 20ML | 223 | MEDICUS ΑΕ | N | 237,69 | 206,79 | 210,93 | 260,58 | ||||
14959 | 287370101 | AXOPLAN CS.SOL.INF 5MG/1ML BTx1VIALx10ML | 686 | MAK A.Σ.Φ.Ε. ΕΙΣΑΓ.& Ε | N | 121,00 | 105,27 | 107,38 | 132,66 | ||||
14960 | 287370102 | AXOPLAN CS.SOL.INF 5MG/1ML BTx1VIALx20ML | 686 | MAK A.Σ.Φ.Ε. ΕΙΣΑΓ.& Ε | N | 232,09 | 201,92 | 205,96 | 254,44 | ||||
55913 | 278110101 | REVLIMID HARD CAPS 5MG/CAP BTx21 σε BLISTERS (PCTFE/PVC/ALU) | 567 | CELGENE EUROPE LTD | N | 4668,51 | 4061,60 | 4142,83 | 5118,05 | ||||
55910 | 278110201 | REVLIMID HARD CAPS 10MG/CAP BTx21 σε BLISTERS (PCTFE/PVC/ALU) | 567 | CELGENE EUROPE LTD | N | 5260,51 | 4576,64 | 4668,17 | 5767,06 | ||||
55911 | 278110301 | REVLIMID HARD CAPS 15MG/CAP BTx21 σε BLISTERS (PCTFE/PVC/ALU) | 567 | CELGENE EUROPE LTD | N | 5536,31 | 4816,59 | 4912,92 | 6069,42 | ||||
55912 | 278110401 | REVLIMID HARD CAPS 25MG/CAP BTx21 σε BLISTERS (PCTFE/PVC/ALU) | 567 | CELGENE EUROPE LTD | N | 6083,47 | 5292,62 | 5398,47 | 6669,27 | ||||
55829 | 278170101 | SEBIVO F.C.TAB 600MG/TAB BTx28 σε BLISTER (PVC/ALU) | 517 | NOVARTIS EUROPHARM | N | 345,48 | 300,57 | 306,58 | 378,75 | ||||
55987 | 279040801 | MIRCERA INJ.SOL 50MCG/0,3ML PF.SYR BTx1PF.SYR | 487 | ROCHE REGISTRATION LT | N | 97,37 | 84,71 | 86,40 | 106,74 | ||||
55988 | 279040901 | MIRCERA INJ.SOL 75MCG/0,3ML PF.SYR BTx1PF.SYR | 487 | ROCHE REGISTRATION LT | N | 140,47 | 122,21 | 124,65 | 153,99 | ||||
55983 | 279041001 | MIRCERA INJ.SOL 100MCG/0,3ML PF.SYR BTx1PF.SYR | 487 | ROCHE REGISTRATION LT | N | 198,99 | 173,12 | 176,58 | 218,15 | ||||
55984 | 279041101 | MIRCERA INJ.SOL 150MCG/0,3ML PF.SYR BTx1PF.SYR | 487 | ROCHE REGISTRATION LT | N | 319,39 | 277,87 | 283,43 | 350,15 | ||||
55985 | 279041201 | MIRCERA INJ.SOL 200MCG/0,3ML PF.SYR BTx1PF.SYR | 487 | ROCHE REGISTRATION LT | N | 389,46 | 338,83 | 345,61 | 426,97 | ||||
55986 | 279041301 | MIRCERA INJ.SOL 250MCG/0,3ML PF.SYR BTx1PF.SYR | 487 | ROCHE REGISTRATION LT | N | 476,74 | 414,76 | 423,06 | 522,65 | ||||
56321 | 279041701 | MIRCERA INJ.SOL 30MCG/0,3ML PF.SYR BTx1PF.SYRx0,3ML | 487 | ROCHE REGISTRATION LT | N | 63,54 | 55,28 | 56,39 | 69,66 | ||||
56320 | 279042001 | MIRCERA INJ.SOL 120MCG/0,3ML PF.SYR BTx1PF.SYRx0,3ML | 487 | ROCHE REGISTRATION LT | N | 250,82 | 218,21 | 222,57 | 274,96 | ||||
56322 | 279042101 | MIRCERA INJ.SOL 360MCG/0,6ML PF.SYR BTx1PF.SYRx0,6ML | 487 | ROCHE REGISTRATION LT | N | 701,05 | 609,91 | 622,11 | 768,55 | ||||
55861 | 279190101 | ATRIANCE INJ.SOL. 5MG/ML VIAL BTx6 VIALx50ML | 491 | GLAXO GROUP LTD, ENGL | N | 1844,40 | 1604,63 | 1636,72 | 2022,00 | ||||
56041 | 281300101 | YONDELIS PD.C.SOL.INF. 0,25MG/VIAL BTx1 VIAL | 603 | PHARMA MAR, S.A. | N | 534,69 | 465,18 | 474,48 | 586,17 | ||||
56042 | 281300201 | YONDELIS PD.C.SOL.INF. 1MG/VIAL BTx1 VIAL | 603 | PHARMA MAR, S.A. | N | 2011,87 | 1750,33 | 1785,34 | 2205,61 | ||||
56030 | 281290101 | TORISEL C.DI.S.INF 25MG/ML BTx1VIAL +1VIAL | 295 | PFIZER HELLAS ΑΕ | N | 942,46 | 819,94 | 836,34 | 1033,21 | ||||
56022 | 280140101 | SIKLOS F.C. TAB 1000MG/TAB BTx30 σε BLISTERS (PVC/PVDC/ALU) | 610 | ADDMEDICA | N | 711,45 | 618,96 | 631,34 | 779,96 | ||||
56026 | 281690103 | TASIGNA HARD.CAPS 200MG/TAB BTx112TABS σε BLISTERS (PVC/OPA | 517 | NOVARTIS EUROPHARM | N | 4092,36 | 3560,35 | 3631,56 | 4486,43 | ||||
56032 | 281500101 | VECTIBIX CS.SOL.INF 100MG/5ML VIAL (20MG/ML) BTx1VIALx5ML | 023 | AMGEN EUROPE B.V. | N | 403,97 | 351,45 | 358,48 | 442,87 | ||||
56285 | 281500301 | VECTIBIX CS.SOL.INF 400MG/20ML VIAL (20MG/ML) BTx1VIALx20ML | 023 | AMGEN EUROPE B.V. | N | 1609,62 | 1400,37 | 1428,38 | 1764,62 | ||||
56102 | 281510102 | RETACRIT INJ.SOL. 1000IU/0,3ML PF.SYR BTx6 PF.SYRSx0,3ML | 654 | HOSPIRA UK LTD | N | 41,34 | 35,97 | 36,69 | 45,33 | ||||
56103 | 281510202 | RETACRIT INJ.SOL. 2000IU/0,6ML PF.SYR BTx6 PF.SYRSx0,6ML | 654 | HOSPIRA UK LTD | N | 76,69 | 66,72 | 68,05 | 84,07 | ||||
56104 | 281510302 | RETACRIT INJ.SOL. 3000IU/0,9ML PF.SYR BTx6 PF.SYRSx0,9ML | 654 | HOSPIRA UK LTD | N | 115,05 | 100,09 | 102,09 | 126,12 | ||||
56106 | 281510402 | RETACRIT INJ.SOL. 4000IU/0,4ML PF.SYR BTx6 PF.SYRSx0,4ML | 654 | HOSPIRA UK LTD | N | 153,40 | 133,46 | 136,13 | 168,18 | ||||
56107 | 281510502 | RETACRIT INJ.SOL. 5000IU/0,5ML PF.SYR BTx6 PF.SYRSx0,5ML | 654 | HOSPIRA UK LTD | N | 191,75 | 166,82 | 170,16 | 210,22 | ||||
56108 | 281510602 | RETACRIT INJ.SOL. 6000IU/0,6ML PF.SYR BTx6 PF.SYRSx0,6ML | 654 | HOSPIRA UK LTD | N | 230,10 | 200,19 | 204,19 | 252,26 | ||||
56109 | 281510702 | RETACRIT INJ.SOL. 8000IU/0,8ML PF.SYR BTx6 PF.SYRSx0,8ML | 654 | HOSPIRA UK LTD | N | 321,15 | 279,40 | 284,99 | 352,08 | ||||
56101 | 281510802 | RETACRIT INJ.SOL. 10000IU/1,0ML PF.SYR BTx6 PF.SYRSx1,0ML | 654 | HOSPIRA UK LTD | N | 377,71 | 328,61 | 335,18 | 414,08 | ||||
56105 | 281511101 | RETACRIT INJ.SOL. 40000IU/1,0ML PF.SYR BTx1 PF.SYRx1,0ML | 654 | HOSPIRA UK LTD | N | 295,11 | 256,75 | 261,89 | 323,54 | ||||
56528 | 281511102 | RETACRIT INJ.SOL. 40000IU/1,0ML PF.SYR BTx4 PF.SYRSx1,0ML | 654 | HOSPIRA UK LTD | N | 1180,49 | 1027,03 | 1047,57 | 1294,17 | ||||
56209 | 283630102 | VOLIBRIS F.C.TAB 5MG/TAB BTx30 σε BLIST (PVC/PVDC/ALU) | 491 | GLAXO GROUP LTD, ENGL | N | 2940,86 | 2558,55 | 2609,72 | 3224,05 | ||||
56208 | 283630202 | VOLIBRIS F.C.TAB 10MG/TAB BTx30 σε BLIST (PVC/PVDC/ALU) | 491 | GLAXO GROUP LTD, ENGL | N | 2940,86 | 2558,55 | 2609,72 | 3224,05 | ||||
56207 | 283710101 | TYVERB FC. TAB 250MG/TAB BTx70 σε BLISTERS (PA/ALU/PVC/ALU) | 491 | GLAXO GROUP LTD, ENGL | N | 1014,18 | 882,34 | 899,99 | 1111,85 | ||||
56215 | 269070101 | ALDURAZYME CS.SOL.INF 100U/ML BTx1VIAL | 465 | GENZYME BV, NEDERLAN | N | 772,78 | 672,32 | 685,77 | 847,20 | ||||
56216 | 280800101 | INCRELEX INJ.SOL 10MG/ML 1VIALx4ML | 712 | IPSEN PHARMA FRANCE | N | 661,00 | 575,07 | 586,57 | 724,65 | ||||
56276 | 283730101 | PRIALT SOL.INF. 100MCG/ML BTx1VIALx1ML | 633 | EISAI LTD | N | 359,69 | 312,93 | 319,19 | 394,33 | ||||
56277 | 283730103 | PRIALT SOL.INF. 100MCG/ML BTx1VIALx5ML | 633 | EISAI LTD | N | 1798,45 | 1564,65 | 1595,94 | 1971,62 | ||||
56239 | 283740101 | INOVELON F.C. TAB 100MG/TAB BTx10 σε BLISTERS (PA/AL/PVC) | 633 | EISAI LTD | N | 5,43 | 4,72 | 4,81 | 5,94 | ||||
56240 | 283740204 | INOVELON F.C. TAB 200MG/TAB BTx60 σε BLISTERS (PA/AL/PVC) | 633 | EISAI LTD | N | 63,03 | 54,84 | 55,94 | 69,11 | ||||
56241 | 283740304 | INOVELON F.C. TAB 400MG/TAB BTx60 σε BLISTERS (PA/AL/PVC) | 633 | EISAI LTD | N | 112,71 | 98,06 | 100,02 | 123,56 | ||||
56306 | 271830101 | GAMINEX SOL. INF 100MG/ML (10% W/V) BTx1VIAL x 10ML | 079 | DEMO AE | N | 82,54 | 71,81 | 73,25 | 90,49 | ||||
56308 | 271830102 | GAMINEX SOL. INF 100MG/ML (10% W/V) BTx1VIAL x 50ML | 079 | DEMO AE | N | 396,30 | 344,78 | 351,68 | 434,47 | ||||
56305 | 271830103 | GAMINEX SOL. INF 100MG/ML (10% W/V) BTx1VIAL x 100ML | 079 | DEMO AE | N | 792,60 | 689,56 | 703,35 | 868,92 | ||||
56307 | 271830104 | GAMINEX SOL. INF 100MG/ML (10% W/V) BTx1VIAL x 200ML | 079 | DEMO AE | N | 1600,00 | 1392,00 | 1419,84 | 1754,07 | ||||
56330 | 285210101 | THALIDOMIDE/CELGENE HARD CAPS 50MG/CAP BTx28 BLISTERS(PVC/ | 567 | CELGENE EUROPE LTD | N | 385,34 | 335,25 | 341,96 | 422,46 | ||||
56392 | 286460101 | FIRAZYR INJ.SOL. 30MG/3ML PF.SYRx3ML (10MG/ML) BTx1PF.SYR.x3M | 656 | JERINI AG | N | 1700,67 | 1479,58 | 1509,17 | 1864,43 | ||||
56389 | 286010102 | EVOLTRA CS.INJ.SOL. 20MG(1MG/ML)/20ML VIAL BTx4 VIALS | 465 | GENZYME BV, NEDERLAN | N | 6804,39 | 5919,82 | 6038,22 | 7459,62 | ||||
56620 | 286010105 | EVOLTRA C.S.SOL.INF 20MG(1MG/ML) 20ML VIAL BTx1 VIAL | 465 | GENZYME BV, NEDERLAN | N | 1656,82 | 1441,43 | 1470,26 | 1816,36 | ||||
57256 | 287230301 | NPLATE (Romiplostim) PD.INJ.SOL 250MCG/VIAL, BTx1VIAL | 653 | AMGEN EUROPE B.V. | N | 613,70 | 533,92 | 544,60 | 672,80 | ||||
57257 | 287230302 | NPLATE (Romiplostim) PD.INJ.SOL 250MCG/VIAL, BTx4VIALS | 653 | AMGEN EUROPE B.V. | N | 2454,80 | 2135,68 | 2178,39 | 2691,18 | ||||
57258 | 287230401 | NPLATE (Romiplostim) PD.INJ.SOL 500MCG/VIAL, BTx1VIAL | 653 | AMGEN EUROPE B.V. | N | 1254,89 | 1091,75 | 1113,59 | 1375,73 | ||||
57259 | 287230402 | NPLATE (Romiplostim) PD.INJ.SOL 500MCG/VIAL, BTx4VIALS | 653 | AMGEN EUROPE B.V. | N | 5019,53 | 4366,99 | 4454,33 | 5502,88 | ||||
56531 | 287160101 | RoACTEMRA CS.SOL.INF 20MG/ML BTx1VIALx4ML | 487 | ROCHE REGISTRATION LT | N | 133,78 | 116,39 | 118,72 | 146,67 | ||||
56534 | 287160102 | RoACTEMRA CS.SOL.INF 20MG/ML BTx4VIALSx4ML | 487 | ROCHE REGISTRATION LT | N | 550,03 | 478,53 | 488,10 | 603,00 | ||||
56529 | 287160103 | RoACTEMRA CS.SOL.INF 20MG/ML BTx1VIALx10ML | 487 | ROCHE REGISTRATION LT | N | 331,79 | 288,66 | 294,43 | 363,74 | ||||
56532 | 287160104 | RoACTEMRA CS.SOL.INF 20MG/ML BTx4VIALSx10ML | 487 | ROCHE REGISTRATION LT | N | 1327,16 | 1154,63 | 1177,72 | 1454,96 | ||||
56530 | 287160105 | RoACTEMRA CS.SOL.INF 20MG/ML BTx1VIALx20ML | 487 | ROCHE REGISTRATION LT | N | 635,89 | 553,22 | 564,28 | 697,11 | ||||
56533 | 287160106 | RoACTEMRA CS.SOL.INF 20MG/ML BTx4VIALSx20ML | 487 | ROCHE REGISTRATION LT | N | 2288,26 | 1990,79 | 2030,61 | 2508,62 | ||||
56541 | 287170101 | STELARA INJ.SOL 45MG(90MG/ML)/0,5ML VIAL BTx1VIALx0,5ML | 550 | JANSSEN-CILAG INT/NAL | N | 3025,80 | 2632,45 | 2685,10 | 3317,17 | ||||
56548 | 287110101 | VIDAZA PD.INJ.SUS 25MG/ML BTx 1 VIAL | 567 | CELGENE EUROPE LTD | N | 362,47 | 315,35 | 321,66 | 397,38 | ||||
56496 | 287120101 | KUVAN SOLU.TAB 100MG/TAB BOTTLEx30 | 504 | MERCK KGAA DEUTSCHLA | N | 720,57 | 626,90 | 639,44 | 789,96 | ||||
56647 | 290950101 | IRESSA F.C. TAB 250mg/TAB, BT X 30 BLIST (PVC/ALU) 3x10 | 688 | AstraZeneca AB | N | 2183,76 | 1899,87 | 1937,87 | 2394,04 | ||||
56679 | 291630101 | MOZOBIL INJ.SOL 20MG/ML BTx1VIALx24MG/1,2ML | 465 | GENZYME BV, NEDERLAN | N | 6125,41 | 5329,11 | 5435,69 | 6715,25 | ||||
56931 | 291640101 | JAVLOR CS.SOL.INF 25MG/ML BTx1VIAL(με γκρι ελαστικό πώμα) Χ2ml | 291 | PIERRE FABRE FARMAKA | N | 226,53 | 197,08 | 201,02 | 248,34 | ||||
56930 | 291640105 | JAVLOR CS.SOL.INF 25MG/ML BTx1VIAL(με γκρι ελαστικό πώμα) Χ10 | 291 | PIERRE FABRE FARMAKA | N | 1132,63 | 985,39 | 1005,10 | 1241,70 | ||||
57054 | 291650101 | SIMPONI IN.SO.PFP 50MG/0,5ML BTx1 PF PENx0,5ML | 701 | CENTOCOR B.V. | N | 1271,91 | 1106,56 | 1128,69 | 1394,38 | ||||
57055 | 291650201 | SIMPONI IN.SO.PFS 50MG/0,5ML BTx1 PF SYRx0,5ML | 701 | CENTOCOR B.V. | N | 1271,91 | 1106,56 | 1128,69 | 1394,38 | ||||
56909 | 291660101 | ILARIS PD.INJ.SOL 150MG BTx1VIAL | 517 | NOVARTIS EUROPHARM | N | 11217,17 | 9758,94 | 9954,12 | 12297,32 | ||||
56774 | 291450101 | CIMZIA Ενέσιμο διάλυμα 200MG BTx2 PF.SYRx1ML+2 τολύπια εμποτισ | 500 | UCB S.A. | N | 917,18 | 797,95 | 813,91 | 1005,50 | ||||
57028 | 293500102 | REVOLADE FC. TAB 25 MG/TAB BTx28 σε BLIST (PA/ALU/PVC/ALU) | 411 | GLAXO SMITHKLINΕ AEBE | N | 1048,51 | 912,20 | 930,44 | 1149,47 | ||||
57029 | 293500202 | REVOLADE FC. TAB 50 MG/TAB BTx28 σε BLIST (PA/ALU/PVC/ALU) | 411 | GLAXO SMITHKLINΕ AEBE | N | 2097,03 | 1824,42 | 1860,91 | 2298,97 | ||||
56762 | 284530101 | BERINERT P.SV INJ.F 500U/VIAL BTx1 VIALx500 U +1 VIALx10ML SOLV | 438 | CSL BEHRING Μ.ΕΠΕ | N | 510,03 | 443,73 | 452,60 | 559,14 | ||||
56759 | 294030101 | ARZERRA CS.SOL.INF 20MG/VIAL BTx3 VIALSx5ML | 411 | GLAXO SMITHKLINΕ AEBE | N | 674,69 | 586,98 | 598,72 | 739,66 | ||||
56758 | 294030102 | ARZERRA CS.SOL.INF 20MG/VIAL BTx10VIALSx5ML | 411 | GLAXO SMITHKLINΕ AEBE | N | 2227,51 | 1937,93 | 1976,69 | 2442,00 | ||||
57306 | 293490101 | GLIOLAN 30MG/ML - POWDER FOR ORAL SOLUTION-1.5G-1 VIAL | 620 | MEDAC GMBH, GERMANY | N | 1094,93 | 952,59 | 971,64 | 1200,36 | ||||
57302 | 295000102 | VOTRIENT FC.TAB 200MG/TAB 1 BOTTLE (HDPE) x 90 | 411 | GLAXOSMITHKLINE AEBE | N | 1952,00 | 1698,24 | 1732,20 | 2139,96 | ||||
57303 | 295000202 | VOTRIENT FC.TAB 400MG/TAB 1 BOTTLE (HDPE) x 60 | 411 | GLAXOSMITHKLINE AEBE | N | 2724,48 | 2370,30 | 2417,71 | 2986,84 | ||||
57520 | 294650101 | MEPACT, Κόνις για εναιώρημα προς έγχυση 4mg/VIAL, 1 VIAL + 1 ΦΙ | 728 | IDM PHARMA S.A.S | N | 3242,57 | 2821,04 | 2877,46 | 3554,81 | ||||
57391 | 295250101 | EPORATIO, INJ.SOL (προγεμισμένη σύριγγα) 1000 IU/0,5ML, BTx6 PF.S | 727 | RATIOPHARM GMBH | N | 36,86 | 32,07 | 32,71 | 40,41 | ||||
57394 | 295250201 | EPORATIO, INJ.SOL (προγεμισμένη σύριγγα) 2000 IU/0,5ML, BTx6 PF.S | 727 | RATIOPHARM GMBH | N | 68,97 | 60,00 | 61,20 | 75,61 | ||||
57397 | 295250301 | EPORATIO, INJ.SOL (προγεμισμένη σύριγγα) 3000 IU/0,5ML, BTx6 PF.S | 727 | RATIOPHARM GMBH | N | 107,34 | 93,39 | 95,26 | 117,68 | ||||
57398 | 295250401 | EPORATIO, INJ.SOL (προγεμισμένη σύριγγα) 4000 IU/0,5ML, BTx6 PF.S | 727 | RATIOPHARM GMBH | N | 138,97 | 120,90 | 123,32 | 152,35 | ||||
57399 | 295250501 | EPORATIO, INJ.SOL (προγεμισμένη σύριγγα) 5000 IU/0,5ML, BTx6 PF.S | 727 | RATIOPHARM GMBH | N | 180,97 | 157,44 | 160,59 | 198,39 | ||||
57390 | 295250605 | EPORATIO, INJ.SOL (προγεμισμένη σύριγγα) 10.000 IU/1ML, BTx6 PF.S | 727 | RATIOPHARM GMBH | N | 331,45 | 288,36 | 294,13 | 363,37 | ||||
57392 | 295250701 | EPORATIO, INJ.SOL (προγεμισμένη σύριγγα) 20.000 IU/1ML, BTx1PF.S | 727 | RATIOPHARM GMBH | N | 110,52 | 96,15 | 98,07 | 121,16 | ||||
57393 | 295250705 | EPORATIO, INJ.SOL (προγεμισμένη σύριγγα) 20.000 IU/1ML, BTx6 PF.S | 727 | RATIOPHARM GMBH | N | 663,17 | 576,96 | 588,50 | 727,03 | ||||
57395 | 295250801 | EPORATIO, INJ.SOL (προγεμισμένη σύριγγα) 30.000 IU/1ML, BTx1PF.S | 727 | RATIOPHARM GMBH | N | 166,09 | 144,50 | 147,39 | 182,09 | ||||
57396 | 295250803 | EPORATIO, INJ.SOL (προγεμισμένη σύριγγα) 30.000 IU/1ML, BTx4 PF.S | 727 | RATIOPHARM GMBH | N | 664,34 | 577,98 | 589,54 | 728,32 | ||||
57624 | 297220102 | PEYONA, SO.INF.ORA 20MG/ML, BT X10AMP X 1ML | 732 | CHIESI FARMACEUTICI SP | N | 234,14 | 203,70 | 207,77 | 256,68 | ||||
51470 | 298250103 | GILENYA CAPS 0.5mg BTx28 PVC/PVDC/alu | 321 | NOVARTIS HELLAS AEΒΕ | N | 1930,00 | 1679,10 | 1712,68 | 2115,84 | ||||
92000 | 245740602 | PEGINTRON REDIPEN 50MCG/0,5ML ΚΟΝΙΣ & ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ | 109 | SCHERING PLOUGH ΑΦΒΕ | N.3816 | 339,22 | 295,12 | 301,02 | 371,88 | ||||
92001 | 245740702 | PEGINTRON REDIPEN 80MCG/0,5ML ΚΟΝΙΣ & ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ | 109 | SCHERING PLOUGH ΑΦΒΕ | N.3816 | 540,44 | 470,18 | 479,58 | 592,47 | ||||
92002 | 245740802 | PEGINTRON REDIPEN 100MCG/0,5ML ΚΟΝΙΣ & ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ | 109 | SCHERING PLOUGH ΑΦΒΕ | N.3816 | 678,31 | 590,13 | 601,93 | 743,62 | ||||
92003 | 245740902 | PEGINTRON REDIPEN 120MCG/0,5ML ΚΟΝΙΣ & ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ | 109 | SCHERING PLOUGH ΑΦΒΕ | N.3816 | 813,88 | 708,08 | 722,24 | 892,26 | ||||
92004 | 245741002 | PEGINTRON REDIPEN 150MCG/0,5ML ΚΟΝΙΣ & ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ | 109 | SCHERING PLOUGH ΑΦΒΕ | N.3816 | 1.037,18 | 902,35 | 920,40 | 1.137,06 |